UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 10-Q

(mark one)

☒x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended ~~March 31~~June 30, 2019

☐o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number 001–34529

STR Holdings, Inc.

(Exact name of registrant as specified in its charter)

Delaware		27–1023344
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

10 Water Street, Enfield, Connecticut		06082
(Address of principal executive offices)		(Zip Code)

(860) 272–4235

(Registrant’s telephone number, including area code)

~~Indicate~~Securities byregistered ~~check~~pursuant ~~mark whether the registrant (1) has filed all reports required~~ to ~~be filed by~~ Section ~~13 or 15~~12(db) of the ~~Securities Exchange~~ Act: of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES ☒ NO ☐None

Indicate by check mark whether the registrant (1) has ~~submitted electronically~~filed ~~and~~all ~~posted~~reports ~~on its corporate Website, if any, every Interactive Data File~~ required to be ~~submitted~~filed ~~and~~by ~~posted~~Section 13 ~~pursuant~~or ~~to Rule 405~~ 15(d) of ~~Regulation~~the ~~S–T~~Securities ~~(§232.405~~Exchange Act of ~~this~~1934 ~~chapter)~~ during the preceding 12 months (or for such shorter period that the registrant was required to ~~submit~~file such reports), and ~~post~~(2) has been subject to such filing ~~files)~~requirements for the past 90 days. YES ☒ x NO ☐o

Indicate by check mark whether the registrant ishas asubmitted ~~large accelerated~~electronically ~~filer,~~every anInteractive ~~accelerated~~Data ~~filer,~~File arequired ~~non–accelerated~~to ~~filer,~~be asubmitted ~~smaller~~pursuant ~~reporting~~to ~~company,~~Rule 405 orof anRegulation ~~emerging~~S–T ~~growth company~~(§232.405 ~~See~~of ~~the~~this chapter) ~~definitions~~during ofthe ~~“large~~preceding ~~accelerated~~12 ~~filer,”~~months ~~“accelerated~~(or ~~filer”~~for ~~“smaller~~such ~~reporting~~shorter ~~company,” and~~period ~~“emerging~~that ~~growth~~the ~~company”~~registrant inwas ~~Rule~~required ~~12b–2~~to ofsubmit ~~the~~such ~~Exchange Act~~files). YES x NO o

~~Large~~Indicate ~~accelerated~~by check mark whether the registrant is a large accelerated filer, ☐an ~~Accelerated~~accelerated filer, ☐a ~~Non~~non–accelerated filer, ☐a ~~Smaller~~smaller reporting company, ☒or ~~Emerging~~an emerging growth company. See the definitions of “large accelerated filer,” ☐“accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b–2 of the Exchange Act.

IfLarge anaccelerated ~~emerging~~filer ~~growth~~o ~~company,~~Accelerated ~~indicate~~filer byo ~~check~~Non–accelerated ~~mark~~filer ifo ~~the~~Smaller ~~registrant has~~reporting ~~elected~~company ~~not~~x toEmerging ~~use~~growth ~~the~~company ~~extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐~~o

~~Indicate~~If an emerging growth company, indicate by check mark ~~whether~~if the registrant has iselected anot ~~shell~~to ~~company (as~~use ~~defined~~the inextended ~~Rule~~transition ~~12b–2~~period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act). ~~YES ☐ NO ☒~~o

~~Securities~~Indicate ~~registered~~by ~~pursuant~~check tomark ~~Section~~whether 12the registrant is a shell company (g)as defined in Rule 12b–2 of the Exchange Act:). YES o NO x

Title of each class	Trading Symbol	Name of each exchange on which registered
Common stock, par value $0.01 per share	STRI	OTCQB Market

At July 31, 2019, there were 20,152,029 shares of Common Stock outstanding.

At April 30, 2019, there were 20,152,029 shares of Common Stock outstanding.

INDEX TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

STR Holdings, Inc. and Subsidiaries

Three and Six Months Ended ~~March~~June 3130, 2019

	PAGE NUMBER
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements	2
Condensed Consolidated Balance Sheets as of March 31, 2019 and December 31, 2018 (unaudited)	2
Condensed Consolidated Balance Sheets as of June 30, 2019 and December 31, 2018 (unaudited)	2
Condensed Consolidated Statements of Comprehensive Income (Loss) for the Three Months Ended March 31, 2019 and 2018 (unaudited)	3
Condensed Consolidated Statements of Comprehensive (Loss) Income for the Three and Six Months Ended June 30, 2019 and 2018 (unaudited)	3
Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2019 and 2018 (unaudited)	4
Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2019 and 2018 (unaudited)	4
Notes to Condensed Consolidated Financial Statements	5
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	1615
Item 3. Quantitative and Qualitative Disclosures About Market Risk	25
Item 4. Controls and Procedures	25
PART II. OTHER INFORMATION
Item 1. Legal Proceedings	25
Item 1A. Risk Factors	26
Item 5. Other Information	26
Item 6. Exhibits	27
SIGNATURE	28

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

STR Holdings, Inc. and Subsidiaries

CONDENSED CONSOLIDATED BALANCE SHEETS

(unaudited)

All amounts in thousands except share and per share amounts

	March 31, 2019			December 31, 2018
	June 30, 2019			December 31, 2018
ASSETS
CURRENT ASSETS
Cash and cash equivalents	$	51,~~536~~969		$	5,639
Accounts receivable, trade, less allowances for doubtful accounts of $2,502 and $2,163 in 2019 and 2018, respectively		1,731			2,261
Accounts receivable, trade, less allowances for doubtful accounts of $2,955 and $2,163 in 2019 and 2018, respectively		1,450			2,261
Inventories, net		1,~~691~~150			1,808
Prepaid expenses		~~643~~689			501
Other current assets		~~766~~532			642
Total current assets		105,~~367~~790			10,851
Property, plant and equipment, net		11,~~675~~616			10,887
Assets held for sale (Note 6)		5,336			5,336
Other long-term assets		7687			75
Total assets	$	2722,~~454~~829		$	27,149
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES
Accounts payable	$	31,~~145~~195		$	2,218
Accrued liabilities (Note 7)		1,~~670~~806			1,348
Income taxes payable		~~902~~903			900
Due to factor		~~248~~209			374
Total current liabilities		54,~~965~~113			4,840
Long-term debt		2,~~244~~274			—
Deferred tax liabilities		~~217~~—			306
Total liabilities		86,~~426~~387			5,146
COMMITMENTS AND CONTINGENCIES (Note 8)
Stockholders’ Equity
Preferred stock, $0.01 par value, 20,000,000 shares authorized; no shares issued and outstanding		—			—
Common stock, $0.01 par value, 200,000,000 shares authorized; 20,153,269 and 20,152,029 issued and outstanding, respectively, in 2019 and 20,153,269 and 20,152,029 issued and outstanding, respectively, in 2018		201			201
Treasury stock, 1,240 shares at cost		(57	)		(57	)
Additional paid–in capital		232,345			232,345
Accumulated deficit		(~~207~~210,~~688~~265	)		(204,832	)
Accumulated other comprehensive loss, net		(5,~~773~~782	)		(5,654	)
Total stockholders’ equity		1916,~~028~~442			22,003
Total liabilities and stockholders’ equity	$	2722,~~454~~829		$	27,149

See accompanying notes to these ~~Condensed~~condensed ~~Consolidated~~consolidated ~~Financial~~financial ~~Statements~~statements.

STR Holdings, Inc. and Subsidiaries

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE ~~INCOME~~ (LOSS) INCOME

(unaudited)

All amounts in thousands except share and per share amounts

	Three Months Ended March 31,
	Three Months Ended June 30,						Six Months Ended June 30,
	2019			2018			2019			2018
Net sales	$	1,~~817~~701		$	32,~~746~~515		$	3,518		$	6,261
Cost of sales		2,~~829~~613			23,~~445~~490			5,442			5,935
Gross (loss) profit		(~~1,012~~912	)		~~1,301~~(975	)		(1,924	)		326
Selling, general and administrative expenses		1,~~337~~225			1,~~692~~380			2,562			3,072
Research and development expense		~~194~~189			~~215~~190			383			405
Provision (recovery) for bad debt expense		304			(61	)
Provision for bad debt expense		486			67			790			6
Operating loss		(2,~~847~~812	)		(~~545~~2,612	)		(5,659	)		(3,157	)
Interest expense, net		(1	)		(1	)
Interest (expense) income, net		(11	)		16			(12	)		15
Other (expense) income, net		(2544	)		~~1,020~~183			(69	)		1,203
Foreign currency transaction loss		(71	)		(56	)
Gain (loss) on disposal of fixed assets		1			(383	)		1			(383	)
(Loss) earnings from operations before income tax (benefit) expense		(2,944	)		418
Foreign currency transaction gain (loss)		71			(106	)		—			(162	)
Income tax (benefit) expense from operations		(88	)		99
Loss before income tax (benefit) expense		(2,795	)		(2,902	)		(5,739	)		(2,484	)
Net (loss) earnings from operations		(2,856	)		319
Income tax (benefit) expense		(218	)		172			(306	)		271
Other comprehensive (loss) earnings:
Net loss	$	(2,577	)	$	(3,074	)	$	(5,433	)	$	(2,755	)
Foreign currency translation (net of tax effect of $(32) and $45, respectively)		(119	)		454
Other comprehensive loss:
Other (loss) earnings comprehensive		(119	)		454
Foreign currency translation (net of tax effect of $16, $(81), $(17) and $(36), respectively)		(9	)		(542	)		(128	)		(88	)
Comprehensive (loss) earnings	$	(2,975	)	$	773
Other comprehensive loss		(9	)		(542	)		(128	)		(88	)
Net (loss) earnings per share (Note 3):
Comprehensive loss	$	(2,586	)	$	(3,616	)	$	(5,561	)	$	(2,843	)
Basic from operations	$	(0.14	)	$	0.02
Net loss per share (Note 3):
Basic	$	(0.1413	)	$	(0.0216	)	$	(0.27	)	$	(0.14	)
Diluted from operations	$	(0.14	)	$	0.02
Diluted	$	(0.13	)	$	(0.16	)	$	(0.27	)	$	(0.14	)
Diluted	$	(0.14	)	$	0.02
Weighted–average shares outstanding (Note 3):
Weighted–average shares outstanding (Note 3):
Basic		20,152,029			19,669,353			20,152,029			19,607,204
Basic		20,152,029			19,571,947
Diluted		20,152,029			19,669,353			20,152,029			19,607,204
Diluted		20,152,029			19,709,356

See accompanying notes to these ~~Condensed~~condensed ~~Consolidated~~consolidated ~~Financial~~financial ~~Statements~~statements.

STR Holdings, Inc. and Subsidiaries

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)

All amounts in thousands

	Three Months Ended March 31,
	Six Months Ended June 30,
	2019			2018
OPERATING ACTIVITIES
Net (loss) earnings	$	(2,856	)	$	319
Net loss	$	(5,433	)		$$(2,755)
Adjustments to reconcile net (loss) earnings to net cash used in operating activities:
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation		~~167~~422			~~199~~383
Stock-based compensation expense		—			74
Stock–based compensation expense		—			161
Provision (recovery) for bad debt expense		304			(61	)
(Gain) loss on disposal of property, plant and equipment		(1	)		383
Provision for deferred taxes		(88	)		99
Provision for bad debt expense		790			6
Provision for inventory adjustment		101			—
(Benefit) provision for deferred taxes		(306	)		271
Customer forfeiture of deposit		—			(~~990~~940	)
Changes in operating assets and liabilities:
Accounts receivable		~~217~~15			96(637	)
Inventories, net		—653			65(269	)
Other current assets		~~(122~~108	)		~~212~~860
Accounts payable		~~689~~(1,293	)		~~(548~~244	)
Accrued liabilities		~~333~~460			~~(62~~67	)
Income taxes payable		13			24
Other, net		~~176~~88			~~160~~150
Total net cash used in operating activities		(14,~~078~~494	)		(~~435~~2,072	)
INVESTING ACTIVITIES
Capital investments		(1,~~183~~230	)		(1236	)
Proceeds from sale of fixed assets		—1			~~225~~238
Total net cash (used in) provided by investing activities		(1,~~183~~229	)		~~213~~202
FINANCING ACTIVITIES
Proceeds from long-term debt		2,~~244~~228			—
Factoring arrangement		(~~119~~161	)		(~~189~~46	)
Total net cash provided by (used in) financing activities		2,~~125~~067			(~~189~~46	)
Effect of exchange rate changes on cash		33(14	)		~~182~~127
Net change in cash and cash equivalents		(~~103~~3,670	)		(~~229~~1,789	)
Cash and cash equivalents, beginning of period		5,639			13,499
Cash and cash equivalents, end of period	$	51,~~536~~969		$	1311,~~270~~710

See accompanying notes to these ~~Condensed~~condensed ~~Consolidated~~consolidated ~~Financial~~financial ~~Statements.~~statements

STR Holdings, Inc. and Subsidiaries

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

All amounts in thousands except share amounts, per share amounts or unless otherwise noted

NOTE 1—BASIS OF PRESENTATION

The accompanying Condensed Consolidated Financial Statements and the related interim information contained within the notes to the Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and the applicable rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial information and quarterly reports on the Form 10-Q. Accordingly, they do not include all of the information and the notes required for complete financial statements. These Condensed Consolidated Financial Statements should be read in conjunction with the consolidated financial statements and notes thereto for the year ended December 31, 2018, included in STR Holdings, Inc.’s (the “Company”) Annual Report on Form 10–K filed with the SEC on March 27, 2019, as amended on April 26, 2019. The unaudited interim Condensed Consolidated Financial Statements have been prepared on the same basis as the audited consolidated financial statements, and in the opinion of management, reflect all adjustments, consisting of only normal and recurring adjustments, necessary for the fair presentation of the Company’s financial position, results of operations and cash flows for the interim periods presented. The results for the interim periods presented are not necessarily indicative of future results.

The year-end Condensed Consolidated Balance Sheet data was derived from audited financial statements, but does not include all disclosures required by GAAP.

The preparation of the Condensed Consolidated Financial Statements in conformity with GAAP requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from management’s estimates.

Liquidity

The Condensed Consolidated Financial Statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. Management has evaluated whether relevant conditions or events, considered in the aggregate, indicate that there is substantial doubt about the Company’s ability to continue as a going concern. Substantial doubt exists when conditions and events, considered in the aggregate, indicate it is probable that the Company will be unable to meet its obligations as they become due during the next 12 months. The assessment is based on the relevant conditions that are known or reasonably knowable as of the date of this report.

If the Company does not generate sufficient cash flows from operations or obtain alternative or additional sources of capital to fund operations, the Company will not have sufficient liquidity to satisfy operating expenses, capital expenditures and other cash needs. This raises substantial doubt about the Company’s ability to continue as a going concern.

The Company has historically incurred significant losses during its attempts to reduce cash burn, stabilize the existing platform and invest in new areas of growth. As of ~~March 31,~~June 30, 2019, the Company had working capital of approximately $41,~~402~~677, approximately $~~800~~400 in outstanding commitments for capital expenditures, and approximately $51,~~536~~969 of cash available to fund ~~our~~its operations. In March 2019, the Company’s ~~entered~~Spanish subsidiary entered into a term loan in the principal amount of €2,000 (approx. $2,~~244~~274 as of ~~March~~June 3130, 2019) to provide additional liquidity in support of its packaging initiative. See Note 12.

Based on the Company’s projected cash requirements for operations and capital expenditures, its current available cash of approximately $51,~~536~~969 and its projected 2019 cash flow pursuant to management’s plans (which includes the completion of the sale of the Company’s Malaysian facility by the end of the fiscal year), management believes it will have adequate resources to fund operations and capital expenditures for at least the next 12 months. If wethe ~~are~~Company is unable to timely complete the sale of ~~our~~its Malaysia facility or execute ~~our~~its strategic plans, ~~our~~its liquidity and capital resources will be adversely affected and wethe Company may wind down or cease any or all of ~~our~~its operations. Any wind down or dissolution ~~may~~ may be a lengthy, complex and costly process and, in such event, there can be no assurance that there will be any funds available ~~for~~ for distribution to stockholders.

NOTE 2—SIGNIFICANT ACCOUNTING POLICIES

Revenue Recognition

Revenue is principally derived from the sale and licensing of highly engineered plastic sheet and film products.

STR Holdings, Inc. and Subsidiaries

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(unaudited)

All amounts in thousands except share amounts, per share amounts or unless otherwise noted

NOTE 2— SIGNIFICANT ACCOUNTING POLICIES ~~(Continued)~~

The Company receives specific purchase orders for the manufacture, sale and delivery of these products that identify the goods and/or services to be transferred, the price for those goods and other commercial terms of the order. The goods are generally purchased under EXW (or EX-Works) terms, meaning that the customer is responsible for arranging the shipping of the goods and title passes when the goods are picked up from the Company’s dock. Revenue is recognized upon the transfer of title, and there are no price concessions, volume discounts, rebates, refunds, credits, incentives, performance bonuses, royalties or other types of variable consideration.Recognition

InRevenue ~~the~~is ~~specific~~principally ~~case~~derived offrom the ~~Equipment~~sale ~~Purchase~~and ~~Agreement~~licensing of highly engineered plastic sheet and afilm ~~Technology~~products. The Company receives specific purchase orders for the manufacture, sale and delivery ~~License~~of ~~Agreement~~these (products that identify the ~~“Agreements”)~~goods ~~signed~~and/or onservices ~~January~~to 16be transferred, ~~2018~~the price for anthose ~~aggregate~~goods ~~transaction~~and ~~price~~other commercial terms of ~~$6,000,~~ the ~~Company will~~order. ~~purchase~~The ~~from~~goods aare ~~third~~generally ~~party~~purchased ~~specialized~~under ~~equipment~~EXW (~~the~~or ~~“Equipment”~~EX-Works) terms, meaning that the customer is responsible for arranging the ~~production~~shipping of ~~one~~the ofgoods and title passes when the goods are picked up from the Company’s ~~proprietary~~ ~~encapsulants~~dock. (Revenue is recognized upon the ~~“Encapsulant”)~~transfer of title, ~~resell~~and ~~the~~there ~~Equipment~~are tono ~~the~~price ~~customer~~concessions, ~~install~~volume ~~the~~discounts, ~~Equipment~~rebates, atrefunds, acredits, ~~facility~~incentives, performance ofbonuses, ~~the~~royalties ~~customer~~or ~~and~~other ~~train~~types ~~the~~of variable consideration.

In the specific case of the Equipment Purchase Agreement and a Technology License Agreement (collectively, the “Original Agreements”) signed on January 16, 2018 for an aggregate transaction price of $6,000, the Company will purchase from a third party specialized equipment (the “Equipment”) for the production of one of the Company’s proprietary encapsulants (the “Encapsulant”), resell the Equipment to the customer, install the Equipment at a facility of the customer and train the customer’s personnel in the Equipment’s use. Under the ~~license~~Technology ~~agreement~~and License Agreement, the Company has granted the customer the right to use the formula for the Encapsulant and certain of the Company’s production techniques to make or have made the Encapsulant for use in photovoltaic (PV) modules manufactured by the customer. For revenue recognition purposes, the Company defines the following three distinct major performance obligations of the Agreements and the corresponding transaction price allocated to those performance obligations:

• Obligation 1 - $1,750 - Price Report, Formula and Sample ~~• Obligation 2 - $2,000 - Equipment, including delivery & installation (incl. training) • Obligation 3 - $2,250 - License (perpetual)~~

•

Obligation 2 - $2,000 - Equipment, including delivery & installation (incl. training)

•

Obligation 3 - $2,250 - License (perpetual)

Obligation 1 is considered to be separate and distinct from the other two obligations, in that the information provided under this obligation represents significant standalone value to the customer and the Company’s obligation to provide this information is separately identifiable from the other obligations in the agreements. Obligation 2 and Obligation 3 were also clearly identifiable, as defined by the Equipment Purchase Agreement (including delivery and installation by an agreed-upon date) and the license (“License”) granted pursuant to the Technology License Agreement (with an effective start date upon the receipt of an acceptance test payment).

The Company is applying a “cost-plus” approach to Obligation 1 and Obligation 2. As the Company had never before sold any type of license, had no established specific license pricing and had no knowledge of pricing for similar licenses, the Company is using the residual approach for Obligation 3. The License is perpetual, distinct and not combined with other goods and services, and is a right to use, rather than to access, functional intellectual property.

The Company also assessed whether it was acting in a principal or agent role in each performance obligation of the Original Agreements. In all obligations, the Company determined it was acting in the role of principal and therefore revenue is recognized on a gross basis.

~~Agreements.~~On InJuly ~~all obligations~~29, 2019 the Company ~~determined~~entered itinto ~~was~~certain ~~acting~~new ~~in the role of principal~~agreements ~~and~~with ~~therefore~~respect ~~revenue~~to isthe ~~recognized~~Original onAgreements. aSee ~~gross~~Note ~~basis~~18.

The Company is presently engaged in discussions of potential modifications to the Agreements with our client that may affect the timing, scope and overall value of the agreement.

Recent Accounting Pronouncements

In February 2016, the FASB issued ASU 2016-02, “Leases (Topic 842).” This ASU requires a lessee to recognize in the statement of financial position a liability to make lease payments and a right-of-use asset representing its right to use the underlying asset for the lease term and also requires additional qualitative and quantitative disclosures. ASU 2016-02 is effective for reporting periods beginning after December 15, 2018, with early adoption permitted. After a thorough assessment, the Company determined that this pronouncement had no impact on its Condensed Consolidated Financial Statements.

There are no other new accounting pronouncements that the Company believes may have a material impact on its Condensed Consolidated Financial Statements.

STR Holdings, Inc. and Subsidiaries

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

All amounts in thousands except share amounts, per share amounts or unless otherwise noted

NOTE 3—(LOSS) ~~EARNINGS~~ PER SHARE

The calculation of basic and diluted net (loss) ~~earnings~~ per share for the periods presented is as follows:

	Three Months Ended March 31,
	Three Months Ended June 30,						Six Months Ended June 30,
	2019			2018			2019			2018
Basic and diluted net (loss) earnings per share
Basic and diluted net loss per share
Numerator:
Net (loss) earnings	$	(2,856	)	$	319
Net loss	$	(2,577	)	$	(3,074	)	$	(5,433	)	$	(2,755	)
Denominator:
Weighted–average shares outstanding		20,152,029			19,~~571~~669,~~947~~353			20,152,029			19,607,204
Add:
Dilutive effect of stock options		—			—			—			—
Dilutive effect of restricted common stock		—			~~137,409~~—			—			—
Weighted–average shares outstanding with dilution		20,152,029			19,~~709~~669,~~356~~353			20,152,029			19,607,204
Net (loss) earnings per share:
Net loss per share:
Basic	$	(0.1413	)	$	(0.0216	)	$	(0.27	)	$	(0.14	)
Diluted	$	(0.1413	)	$	(0.0216	)	$	(0.27	)	$	(0.14	)

Due to the net loss ~~from operations~~ for the three and six months ended ~~March 31~~June 30, 2019 and 2018, the computation of dilutive weighted-average common shares outstanding does not include any stock options or any ~~shares~~ shares of unvested restricted common stock as these potential awards are anti-dilutive.

Because the effect would be anti-dilutive, there were 1,121,332 stock options outstanding that were not included in the computation of diluted weighted-average shares outstanding for each of the three and six months ended ~~March 31~~June 30, 2019 and 2018.

NOTE 4—INVENTORIES

Inventories consist of the following:

	March 31, 2019			December 31, 2018
	June 30, 2019			December 31, 2018
Finished goods	$	~~433~~155		$	544
Raw materials		1,~~363~~123			1,274
Reserve		(~~105~~128	)		(10	)
Inventories, net	$	1,~~691~~150		$	1,808

NOTE 5—LONG–-LIVED ASSETS

Impairment Testing

In accordance with ASC 360-Property, Plant and Equipment, the Company assesses the impairment of its long-lived assets whenever changes in events or circumstances indicate that the carrying value of such assets may not be recoverable. During each reporting period, the Company assessed if the following factors were present, which would cause an impairment review: overall negative solar industry conditions; a significant or prolonged decrease in net sales generated under its trademarks; loss of a significant customer or a reduction in demand for customers’ products; a significant adverse change in the extent to or manner in which the Company used its trademarks or proprietary technology; such assets becoming obsolete due to new technology or manufacturing processes entering the markets or an adverse change in legal factors; and the market capitalization of the Company’s common stock.

At March 31, 2019 and December 31, 2018, the Company recorded valuation allowances against its deferred tax assets. The valuation allowances were recorded since the Company had three consecutive years of taxable losses and determined that its history of actual net losses was evidence that should be given more weight than future projections. The Company determined the recording of valuation allowances against deferred tax assets to be an indicator to test its long-lived assets, which consist solely of property, plant and equipment, for impairment. The Company assessed the specific

STR Holdings, Inc. and Subsidiaries

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS ~~(Continued)~~

(unaudited)

All amounts in thousands except share amounts, per share amounts or unless otherwise noted

NOTE 5—LONG–LIVED ASSETS (Continued)

At June 30, 2019 and December 31, 2018, the Company recorded valuation allowances against its deferred tax assets. The valuation allowances were recorded since the Company had three consecutive years of taxable losses and determined that its history of actual net losses was evidence that should be given more weight than future projections. The Company determined the recording of valuation allowances against deferred tax assets to be an indicator to test its long-lived assets, which consist solely of property, plant and equipment, for impairment. The Company assessed the specific recoverability of its property, plant and equipment using updated real estate appraisals and other data for its other fixed assets, mainly production equipment. Based upon this analysis, the Company believes its property, plant and equipment carrying value was recoverable and depreciable lives were appropriate as of ~~March~~June 3130, 2019. Therefore no impairment was recorded in 2019. If the Company experiences a significant reduction in future sales volume, further average selling price (“ASP”) reductions, lower profitability, a cessation of operations at any of its facilities, or negative changes in U.S. or Spain real estate markets, the Company’s property, plant and equipment may be subject to future impairment or accelerated depreciation.

NOTE 6—ASSETS HELD FOR SALE

In July 2015, the Company announced a restructuring plan, effective August 2, 2015, that included the closure of its Johor, Malaysia facility ~~effective August 2, 2015~~. Subsequent to the announcement, the Company engaged ~~advisors~~ advisors and was actively trying to sell its land-use right, building and other fixed assets located at the facility. ~~During 2016, the Company entered into a definitive~~

~~Purchase~~On ~~and~~November ~~Sale~~1, ~~Agreement~~2018, ~~for~~ the ~~land~~Company received a non-~~use~~binding ~~right~~letter ~~and~~of intent ~~the~~from ~~building~~a potential buyer for aits ~~purchase~~Johor, ~~price of~~Malaysia ~~RM25~~facility for RM22,~~000~~500 (approximately $65,~~123~~336, after realtor fees, as of ~~March 31~~June 30, 2019) and subsequently entered into a Purchase and Sale Agreement with this buyer effective January 10, 2019. ~~Closing~~The agreement provides that the closing of the ~~transaction~~sale ~~was~~is subject to various customary ~~conditions~~and toregulatory ~~closing of~~approvals ~~transactions~~and ~~of this type~~conditions, including the approval of the Johor Port Authority ~~(“JPA”)~~. OnThe ~~July~~agreement ~~31,~~further ~~2017,~~provides that if the ~~Company received~~closing adid ~~notice~~not ~~from~~occur ~~the~~within ~~purchaser~~six ~~purporting~~months toeither party may terminate the agreement, ~~alleging~~however ~~that~~the Company and the ~~JPA~~buyer ~~was~~have ~~seeking~~agreed to ~~impose~~extend ~~certain conditions~~the onclosing ~~the~~window ~~approval~~by ofan ~~the~~additional ~~transfer~~six ofmonths to ~~the~~allow ~~facility~~for topotential ~~the~~delays ~~purchaser~~in ~~that~~obtaining itthe ~~found~~necessary ~~unacceptable~~approvals. The ~~Company~~sale ~~was~~of ~~not~~the ~~successful~~property is part of the Company’s focus into ~~removing~~reduce ~~those~~its ~~conditions~~footprint and ~~the~~operating ~~agreement terminated~~costs.

OnIn ~~November~~accordance 1,with ~~2018,~~ASC ~~the Company received a non~~360-~~binding letter of intent from a potential buyer for its Johor~~Property, ~~Malaysia~~Plant ~~facility~~and ~~for RM22~~Equipment,~~500~~ ~~(approximately~~the ~~$5,400, after realtor fees, as of March~~Company ~~31,~~assessed ~~2019)~~the ~~and~~asset ~~subsequently~~group ~~entered~~attributed ~~into~~to athe ~~Purchase~~sale ~~and~~for ~~Sale~~impairment. ~~Agreement~~Based ~~with~~upon ~~this~~the ~~buyer~~Company’s ~~effective~~assessment ~~January~~of ~~10, 2019. The agreement provides that~~ the ~~closing~~status of the Malaysia ~~sale~~property, isplant ~~subject to various customary~~ and ~~regulatory approvals and conditions~~equipment, ~~including~~all ~~the approval~~ of the ~~JPA.~~requirements ~~The~~(including ~~agreement further provides that if~~ the ~~conditions~~held tofor ~~the~~sale ~~closing~~requirements) ~~are~~set ~~not~~forth ~~net~~in ~~and~~ASC ~~the closing does not occur within~~360-10-45-9 ~~six~~were ~~months~~met ~~either party may terminate the agreement, although the Company~~ and the ~~buyer~~assets ~~expect~~were toclassified ~~sign~~on ~~an amendment to extend~~ the ~~closing~~ ~~window~~Condensed byConsolidated anBalance ~~additional~~Sheet ~~six~~as ~~months~~of toJune ~~allow~~30, ~~for~~2019 ~~potential~~and ~~delays~~December 31, ~~in obtaining the necessary approvals. The sale of the~~2018 ~~property~~as isassets ~~part~~held offor ~~the Company’s focus to reduce its footprint and operating costs~~sale.

In accordance with ASC 360-Property, Plant and Equipment, the Company assessed the asset group attributed to the sale for impairment. Based upon the Company’s assessment of the status of the Malaysia property, plant and equipment, all of the requirements (including the held for sale requirements) set forth in ASC 360-10-45-9 were met and the assets were classified on the Condensed Consolidated Balance Sheet as of March 31, 2019 and December 31, 2018 as assets held for sale.

NOTE 7—ACCRUED LIABILITIES

Accrued liabilities consist of the following:

	March 31, 2019		December 31, 2018
	June 30, 2019		December 31, 2018
Salary and wages	$	238	$	181
Salaries and wages	$	343	$	181
Accrued bonus		~~387~~500		326
Professional fees		~~317~~362		238
Restructuring severance and benefits (see Note 9)		~~103~~89		102
Environmental (see Note 8)		57		57
Accrued franchise tax		~~222~~136		164
Client deposits		~~265~~197		224
Other		81122		56
Total	$	1,670	$	1,348
Total accrued liabilities	$	1,806	$	1,348

NOTE 8—COMMITMENTS AND CONTINGENCIES

The Company is a party to claims and litigation in the normal course of its operations. Management believes that the ultimate outcome of these matters will not have a material adverse effect on the Company’s financial position, results of operations, or cash flows.

STR Holdings, Inc. and Subsidiaries

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS ~~(Continued)~~

(unaudited)

All amounts in thousands except share amounts, per share amounts or unless otherwise noted

NOTE 8—COMMITMENTS AND CONTINGENCIES (Continued)

Product Performance ~~Matters~~

The Company provides a short-term warranty that it has manufactured its products to the Company’s specifications. On limited occasions, the Company incurs costs to service its products in connection with specific product performance matters that do not meet the Company’s specifications. Anticipated future costs are recorded as part of cost of sales and accrued liabilities for specific product performance matters when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated.

On isolated occasions, the Company has also offered limited short-term performance warranties relating to its encapsulants not causing module power loss. The Company’s encapsulants are validated by long-term performance testing during product development prior to launch and during customer certification prior to mass production. The Company has operated its solar business since the 1970s and over 20 GW of solar modules incorporating its encapsulants have been installed in the field with no reported module power performance issues caused by the Company’s encapsulants and no related warranty claims to date. Based on this fact pattern, the Company has not accrued any warranty liability associated for this potential liability as its occurrence is deemed to be remote. If the Company was to ever receive a warranty claim for such matter, the Company would assess the need for a warranty accrual at that time.

The Company’s product performance liability that is recorded in accrued liabilities in the Condensed Consolidated Balance Sheets was $0 as of ~~March~~June 3130, 2019 and December 31, 2018.

Environmental

During 2010, the Company performed a Phase II environmental site assessment at its 10 Water Street, Enfield, Connecticut location. During its investigation, the site was found to contain a presence of volatile organic compounds. The Company has been in contact with the Department of Environmental Protection and has engaged a licensed contractor to remediate this circumstance. Based on ASC 450-Contingencies, the Company has accrued the estimated cost to remediate. The Company’s environmental liability that is recorded in accrued liabilities in the Condensed Consolidated Balance Sheets was $57 as of ~~March~~June 3130, 2019 and December 31, 2018.

Solaria

In October 2016, a complaint was filed by Solaria Energia y Medio Ambiente S.A.U. (“Solaria”) against the Company and its Spanish subsidiary, Specialized Technology Resources España, S.A.U. (“STR Spain”), in the Court of the First Instance No. 8 in Oviedo, Spain, relating to a product quality claim in connection with a non-encapsulant product that STR Spain purchased from a vendor in 2005 and 2006 and resold to Solaria. The Company stopped selling this product in 2006. Solaria was seeking approximately €3,300, plus interest, in damages.

~~STR~~A trial was held on April 6, 2017 in Oviedo, Spain. ~~purchased~~On ~~from~~January 9, 2019, the judge issued a ~~vendor~~ruling indismissing ~~2005~~Solaria’s case, and ~~2006~~the ~~and~~appeal ~~resold~~period toended ~~Solaria.~~on ~~The~~February ~~Company~~8, 2019 with no appeal ~~stopped~~filed. ~~selling~~As ~~this~~a ~~product~~result, inno ~~2006.~~accrual ~~Solaria~~relating to this complaint was ~~seeking~~recorded ~~approximately~~as €3of June 30,~~300,~~ ~~plus~~2019 ~~interest~~and December 31, in2018 ~~damages~~and the Company considers the matter closed.

ANOTE ~~trial was held on April 6, 2017 in Oviedo, Spain. On January~~ 9~~, 2019,~~—COST-REDUCTION the judge issued a ruling dismissing Solaria’s case, and the appeal period ended on February 8, 2019 with no appeal filed. As a result, no accrual relating to this complaint was recorded as of March 31, 2019 and December 31, 2018 and the Company considers the matter closed.ACTIONS

NOTE 9—COST–REDUCTION ACTIONS

In March 2017, the Company made the decision to wind down its China manufacturing operations substantially by the end of the second quarter of 2017. The decision was consistent with ongoing efforts to reorganize its business to better align with customer geography, to reduce losses related to unprofitable locations and to convert assets to cash for potential redeployment into more profitable endeavors. In connection with the restructuring, the Company does not expect any significant asset impairment charges and recorded $112 of severance charges and benefits in cost of sales and $29 of severance charges and benefits in selling, general and administrative expenses during 2017 and $67 of severance charges during 2018. The Company sold certain production and testing equipment from the China facility to its tolling partner in India during the third quarter of 2017.

In June 2018, the Company eliminated certain positions at its Spain facility, effective June 18, 2018. The Company recorded $635 of severance and benefits in cost of sales and $67 of severance and benefits in selling, general and administrative expenses during 2018.

STR Holdings, Inc. and Subsidiaries

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS ~~(Continued)~~

(unaudited)

All amounts in thousands except share amounts, per share amounts or unless otherwise noted

NOTE 9—COST–-REDUCTION ACTIONS (Continued)

The restructuring accrual consists of $~~102~~89 for severance and benefits as of ~~March~~June 3130, 2019. A rollforward of the severance and other exit cost accrual activity is as follows:

	March 31, 2019			March 31, 2018
	June 30, 2019			June 30, 2018
Balance as of beginning of period	$	102		$	87
Balance as of beginning of year	$	102		$	87
Additions		—			67722
Reductions		—(13	)		(29707	)
Balance as of end of period	$	~~102~~89		$	~~125~~102

NOTE 10—FAIR VALUE MEASUREMENTS

The Company measures certain financial assets and liabilities at fair value on a recurring basis in the financial statements. The hierarchy ranks the quality and reliability of inputs, or assumptions, used in the determination of fair value and requires financial assets and liabilities carried at fair value to be classified and disclosed in one of the following three categories:

~~and~~· ~~requires~~Level ~~financial~~1-quoted ~~assets~~prices ~~and~~(unadjusted) ~~liabilities~~in ~~carried~~active atmarkets ~~fair~~for ~~value~~identical toassets ~~be classified~~ and ~~disclosed in one of the following three categories:~~liabilities;

•· Level 12-unadjusted quoted prices ~~(unadjusted)~~ in active markets for similar assets or liabilities, or unadjusted quoted prices for identical or similar assets ~~and~~or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability; and

•· Level 23-~~unadjusted~~unobservable ~~quoted~~inputs ~~prices in active markets for similar assets or liabilities, or unadjusted quoted prices for identical or similar assets or liabilities in markets~~ that are not ~~active,~~corroborated orby ~~inputs~~market ~~other than quoted prices that are observable for the asset or liability; and~~data.

•The ~~Level~~following ~~3-unobservable~~table ~~inputs~~provides ~~that~~the ~~are~~fair ~~not~~value ~~corroborated~~measurements byof ~~market~~applicable financial ~~data.~~assets and liabilities as of June 30, 2019:

The following table provides the fair value measurements of applicable financial assets and liabilities as of March 31, 2019:

	Financial assets and liabilities at fair value as of June 30, 2019
	Level 1		Level 2		Level 3

Money market funds (1)	$	758	$	—	$	—
Non-recurring fair value measurements (2)		—		—		5,336
Total	$	758	$	—	$	5,336

	Financial assets and liabilities at fair value as of March 31, 2019
	Level 1		Level 2		Level 3
Money market funds (1)	$	1,266	$	—	$	—
Non-recurring fair value measurements (2)	$	—	$	—	$	5,336
Total	$	1,266	$	—	$	5,336

The following table provides the fair value measurements of applicable financial assets and liabilities as of December 31, 2018:

	Financial assets and liabilities at fair value as of December 31, 2018
	Level 1		Level 2		Level 3
Money market funds (1)	$	2,494	$	—	$	—
Non-recurring fair value measurements (2)	$	—	$	—	$	5,336
Total	$	2,494	$	—	$	5,336

_________________

(1)

Included in cash and cash equivalents on the Company’s Condensed Consolidated Balance Sheets. The carrying amount of money market funds is a reasonable estimate of fair value due to the short-term maturity.

(2)

Included in assets held for sale on the Company’s Condensed Consolidated Balance Sheets. Refer to Note 6 for further information.

NOTE 11—FACTORING ARRANGEMENT

In October 2015, the Company’s wholly owned Spanish subsidiary, STR Spain, entered into a factoring agreement to sell, with recourse, certain European, U.S. and other foreign company-based receivables to Eurofactor Hispania S.A.U., who was later acquired by Credit Agricole Leasing and Factoring Sucursal en España during the first quarter of 2017. Under the current terms of the factoring agreement, the maximum amount of outstanding advances at any one time is €1,500 (approximately $1,683 as of March 31, 2019), which is subject to adjustment based on the level of eligible receivables, restrictions on concentrations of receivables and the historical performance of the receivables sold. The annual discount rate is 2% plus EURIBOR for Euro denominated receivables and 2% plus LIBOR for all other currencies. The term of the agreement is for one year, which will be automatically extended unless terminated by either party with 90 days prior written notice. As of March 31, 2019 and December 31, 2018 the Company has recorded $248 and $374, respectively, as due to factor on the Condensed Consolidated Balance Sheets.

STR Holdings, Inc. and Subsidiaries

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS ~~(Continued)~~

(unaudited)

All amounts in thousands except share amounts, per share amounts or unless otherwise noted

NOTE 11—FACTORING ARRANGEMENT

In October 2015, the Company’s wholly owned Spanish subsidiary, STR Spain, entered into a factoring agreement to sell, with recourse, certain European, U.S. and other foreign company-based receivables to Eurofactor Hispania S.A.U., who was later acquired by Credit Agricole Leasing and Factoring Sucursal en España during the first quarter of 2017. Under the current terms of the factoring agreement, the maximum amount of outstanding advances at any one time is €1,500 (approximately $1,706 as of June 30, 2019), which is subject to adjustment based on the level of eligible receivables, restrictions on concentrations of receivables and the historical performance of the receivables sold. The annual discount rate is 2% plus EURIBOR for Euro denominated receivables and 2% plus LIBOR for all other currencies. The term of the agreement is for one year, which will be automatically extended unless terminated by either party with 90 days prior written notice. As of June 30, 2019 and December 31, 2018 the Company has recorded $209 and $374, respectively, as due to factor on the Condensed Consolidated Balance Sheets.

NOTE 12—LONG-TERM DEBT

On March 13, 2019, the Company’s wholly owned subsidiary, STR Spain, entered into a Loan with Mortgage Guarantee (the “Loan Agreement”) with the Regional Society of Promotion of the Principality of Asturias, SA (the “Lender”), for a term loan (the “Loan”) in the aggregate principal amount of a €2,000 ($2,~~244~~274 as of ~~March~~June 3130, 2019). STR Spain is required to use the loan proceeds to help finance the launch and operation of its food packaging business. The Loan matures on December 31, 2025, with principal due and payable in equal quarterly installments of €100 each, commencing on March 31, 2021. Interest, which is payable quarterly in arrears, accrues at the annual EURIBOR rate (as such term is defined in the Loan agreement) plus an applicable margin. During the first two years, the applicable margin is 2%, and thereafter increases by 1% per year until the applicable margin is 5% in the fifth year of the Loan. The Loan may be prepaid at any time without premium or penalty. The Loan is secured by a mortgage of STR Spain’s business and certain facilities, and contains customary covenants, including a covenant prohibiting STR Spain from making distributions to the Company, as sole shareholder, without the prior approval of the Lender. In connection with the Loan, the Company has separately agreed to provide STR Spain with resources to support the Loan and the continuity of the packaging initiative.

NOTE 13—INCOME TAXES ~~FROM OPERATIONS~~

OnDuring ~~December 22, 2017,~~ the ~~Tax~~three ~~Cuts~~ and ~~Jobs~~six ~~Act~~months ~~(“TCJA”) was~~ended ~~enacted~~June ~~into~~30, ~~law~~2019, in the ~~United~~Company recorded ~~States.~~an ~~The~~income ~~legislation~~tax ~~contains~~benefit ~~several~~of ~~key~~$218 ~~tax~~and ~~provisions~~$306 ~~including~~resulting ~~the~~in ~~reduction~~an ofeffective ~~the corporate income~~ tax rate toof 217.8% ~~effective~~and ~~January 1~~5.3%, ~~2018,~~respectively. aThis ~~one-time transition~~ effective tax onrate ~~foreign~~for ~~earnings~~the ~~which~~three ~~have~~months ~~not~~ended ~~previously~~June ~~been subject~~30, to2019 ~~tax~~differs infrom the ~~United~~U.S. ~~States,~~statutory astax ~~well~~rate asprimarily adue ~~variety~~to ~~of other changes, including limitation of~~ the ~~tax~~effect ~~deductibility~~ of ~~interest expense, limitations for the deduction for net operating losses, new~~ taxes on ~~certain~~ foreign~~-sourced~~ earnings~~, and modification or repeal of many business deductions and credits~~.

~~The~~During ~~TCJA~~the ~~subjects~~three aand ~~U.S.~~six ~~shareholder~~months toended ~~tax~~June on30, ~~global~~2018, ~~intangible~~the Company ~~low-taxed~~recorded an income tax expense of $172 and $271 resulting in an effective tax rate of (~~GILTI~~5.9%) ~~earned~~and by(10.9%), ~~certain~~respectively. ~~foreign~~This ~~subsidiaries~~effective tax rate for ~~which~~the anthree ~~entity~~months ~~can~~ended ~~make~~June an30, ~~accounting~~2018 ~~policy~~differs ~~election~~from the U.S. statutory tax rate primarily due to ~~either recognize~~the ~~deferred~~effect of taxes on ~~for~~foreign earnings.

~~temporary~~NOTE ~~basis~~14—STOCKHOLDERS’ differences expected to reverse as GILTI in future years or provide for the tax expense related to GILTI in the year the tax is incurred. In 2018, the Company made the election to use the period cost method and will treat taxes due related to GILTI as a current-period expense when incurred. As of March 31, 2019, the Company does not anticipate a GILTI inclusion for the taxable year.EQUITY

~~During~~Changes ~~the three months ended March 31, 2019, the Company recorded an income tax benefit of $88 resulting~~ in anstockholders’ ~~effective~~equity ~~tax rate of 3.0%. This effective tax rate~~ for the ~~three~~six months ended ~~March~~June 3130, 2019 ~~differs~~are ~~from~~as ~~the U.S. statutory tax rate primarily due to the effect of taxes on foreign earnings.~~follows:

During the three months ended March 31, 2018, the Company recorded an income tax expense of $99 resulting in an effective tax rate of 23.7%. This effective tax rate for the three months ended March 31, 2018 differs from the U.S. statutory tax rate primarily due to the effect of taxes on foreign earnings.

	Common Stock				Treasury Stock					Additional Paid-In		Accumulated Other Comprehensive			Accumulated			Total Stockholders’
	Issued		Amount		Acquired		Loss			Capital		Loss			Deficit			Equity
Balance at December 31, 2018		20,152,029	$	201		1,240	$	(57	)	$	232,345	$	(5,654	)	$	(204,832	)	$	22,003
Net earnings		—		—		—		—			—		—			(5,433	)		(5,433	)
Foreign currency translation, net of tax		—		—		—		—			—		(128	)		—			(128	)
Balance at June 30, 2019		20,152,029	$	201		1,240	$	(57	)	$	232,345	$	(5,782	)	$	(210,265	)	$	16,442

Common Stock

The Company’s Board of Directors has authorized 200,000,000 shares of common stock, $0.01 par value. At June 30, 2019, there were 20,153,269 shares issued and 20,152,029 shares outstanding of common stock. Each share of common stock is entitled to one vote per share.

STR Holdings, Inc. and Subsidiaries

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS ~~(Continued)~~

(unaudited)

All amounts in thousands except share amounts, per share amounts or unless otherwise noted

NOTE 1415—~~STOCKHOLDERS’~~STOCK-BASED ~~EQUITY~~COMPENSATION

~~Changes~~On inNovember 6, ~~stockholders~~2009, the Company’s ~~equity~~Board of Directors approved the Company’s 2009 Equity Incentive Plan (the “2009 Plan”) which became effective on the same day. Effective May 14, 2013, the 2009 Plan was amended to increase the number of shares subject to the Plan. As a result, a total of 4,133,133 shares of common stock are reserved for issuance under the ~~three~~2009 ~~months~~Plan. ~~ended~~The 2009 Plan is administered by the Board of Directors or ~~March~~any 31committee designated by the Board of Directors, ~~2019~~which has the authority to designate participants and determine the number and type of awards to be granted, the time at which awards are exercisable, the method of payment and any other terms or conditions of the awards. The 2009 Plan provides for the grant of stock options, including incentive stock options and nonqualified stock options, collectively, “options,” stock appreciation rights, shares of restricted stock, or “restricted stock,” rights to dividend equivalents and other stock-based awards, collectively, the “awards.” The Board of Directors or the committee will, with regard to each award, determine the terms and conditions of the award, including the number of shares subject to the award, the vesting terms of the award, and the purchase price for the award. Awards may be made in assumption of or in substitution for outstanding awards previously granted by the Company or its affiliates, or a company acquired by the Company or with which it combines. Options outstanding generally vest over a three or four-year period and expire ten years from date of grant. There were 317,323 shares available for grant under the 2009 Plan as ~~follows:~~of June 30, 2019.

	Common Stock				Treasury Stock					Additional Paid-In		Accumulated Other Comprehensive			Accumulated			Total Stockholders’
	Issued		Amount		Acquired		Loss			Capital		Loss			Deficit			Equity
Balance at December 31, 2018		20,152,029	$	201		1,240	$	(57	)	$	232,345	$	(5,654	)	$	(204,832	)	$	22,003
Net earnings		—		—		—		—			—		—			(2,856	)		(2,856	)
Foreign currency translation, net of tax		—		—		—		—			—		(119	)		—			(119	)
Balance at March 31, 2019		20,152,029	$	201		1,240	$	(57	)	$	232,345	$	(5,773	)	$	(207,688	)	$	19,028

The following table summarizes the options activity under the Company’s 2009 Plan for the six months ended June 30, 2019:

Common Stock

	Options Outstanding
	Number of Shares		Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (in years)		Weighted- Average Grant-Date Fair Value		Aggregate Intrinsic Value(1)
Balance at December 31, 2018		1,121,332	$	1.52		—	$	0.99	$	—
Options granted		—	$	—		—	$	—	$	—
Exercised		—	$	—		—	$	—	$	—
Cancelled/forfeited		—	$	—		—	$	—	$	—
Balance at June 30, 2019		1,121,332	$	1.52		5.61	$	0.99	$	—
Vested and exercisable as of June 30, 2019		1,121,332	$	1.52		5.61	$	0.99	$	—
Vested and exercisable as of June 30, 2019 and expected to vest thereafter		1,121,332	$	1.52		5.61	$	0.99	$	—

(1) The ~~Company’s~~aggregate ~~Board~~intrinsic ofvalue ~~Directors~~is ~~has~~calculated ~~authorized~~as ~~200,000,000~~the difference between the ~~shares~~exercise price of ~~common~~the underlying awards and the closing stock, price of $0.0118 ~~par~~of ~~value.~~the AtCompany’s ~~March~~common ~~31,~~stock ~~2019,~~on ~~there~~June ~~were 20~~30,~~153,269~~ ~~shares~~2019 (to ~~issued~~the ~~and~~extent ~~20,152,029~~that ~~shares~~the ~~outstanding of~~closing ~~common~~ stock. ~~Each~~price ~~share~~exceeds ofthe ~~common~~exercise price).

As of June 30, 2019, there was $0 of unrecognized compensation cost related to outstanding stock isoption ~~entitled~~awards. The Company did not receive any proceeds related to ~~one~~the ~~vote~~exercise ~~per~~of ~~share~~stock options for the six months ended June 30, 2019.

~~NOTE~~Stock-based ~~15—STOCK–BASED~~compensation ~~COMPENSATION~~expense was included in the following Condensed Consolidated Statements of Comprehensive Loss categories for operations:

On November 6, 2009, the Company’s Board of Directors approved the Company’s 2009 Equity Incentive Plan (the “2009 Plan”) which became effective on the same day. Effective May 14, 2013, the 2009 Plan was amended to increase the number of shares subject to the Plan. As a result, a total of 4,133,133 shares of common stock are reserved for issuance under the 2009 Plan. The 2009 Plan is administered by the Board of Directors or any committee designated by the Board of Directors, which has the authority to designate participants and determine the number and type of awards to be granted, the time at which awards are exercisable, the method of payment and any other terms or conditions of the awards. The 2009 Plan provides for the grant of stock options, including incentive stock options and nonqualified stock options, collectively, “options,” stock appreciation rights, shares of restricted stock, or “restricted stock,” rights to dividend equivalents and other stock-based awards, collectively, the “awards.” The Board of Directors or the committee will, with regard to each award, determine the terms and conditions of the award, including the number of shares subject to the award, the vesting terms of the award, and the purchase price for the award. Awards may be made in assumption of or in substitution for outstanding awards previously granted by the Company or its affiliates, or a company acquired by the Company or with which it combines. Options outstanding generally vest over a three or four-year period and expire ten years from date of grant. There were 317,323 shares available for grant under the 2009 Plan as of March 31, 2019.

	Three Months Ended June 30,				Six Months Ended June 30,
	2019		2018		2019		2018
Selling, general and administrative expense	$	—	$	88	$	—	$	161
Total stock-based compensation expense	$	—	$	88	$	—	$	161

STR Holdings, Inc. and Subsidiaries

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS ~~(Continued)~~

(unaudited)

All amounts in thousands except share amounts, per share amounts or unless otherwise noted

NOTE 15—STOCK–BASED COMPENSATION (Continued)

The following table summarizes the options activity under the Company’s 2009 Plan for the three months ended March 31, 2019:

	Options Outstanding
	Number of Shares		Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (in years)		Weighted- Average Grant-Date Fair Value		Aggregate Intrinsic Value(1)
Balance at December 31, 2018		1,121,332	$	1.52		—	$	0.99	$	—
Options granted		—	$	—		—	$	—	$	—
Exercised		—	$	—		—	$	—	$	—
Cancelled/forfeited		—	$	—		—	$	—	$	—
Balance at March 31, 2019		1,121,332	$	1.52		5.86	$	0.99	$	—
Vested and exercisable as of March 31, 2019		1,121,332	$	1.52		5.86	$	0.99	$	—
Vested and exercisable as of March 31, 2019 and expected to vest thereafter		1,121,332	$	1.52		5.86	$	0.99	$	—

_________________

(1) The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the closing stock price of $0.32 of the Company’s common stock on March 31, 2019 (to the extent that the closing stock price exceeds the exercise price).

As of March 31, 2019, there was $0 of unrecognized compensation cost related to outstanding stock option awards. The Company did not receive any proceeds related to the exercise of stock options for the year ended March 31, 2019.

Stock-based compensation expense was included in the following Condensed Consolidated Statements of Comprehensive Income (Loss) categories for operations:

	Three Months Ended March 31,
	2019		2018
Selling, general and administrative expense	$	—	$	74
Total stock-based compensation expense	$	—	$	74

NOTE 16—GEOGRAPHICAL INFORMATION

ASC 280-10-50, “ Disclosure about Segments of an ~~Enterprise~~ Enterprise and Related Information,” establishes standards for the manner in which companies report information about operating segments, products, geographic areas and major customers. The method of determining what information to report is based on the way that management organizes the operating segment within the enterprise for making operating decisions and assessing financial performance. Since the Company has one product, sells to global customers in one industry, procures raw materials from similar vendors and expects similar long-term economic characteristics, the Company has one reporting segment and the information as to its operation is set forth below.

STR Holdings, Inc. and Subsidiaries

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(unaudited)

All amounts in thousands except share amounts, per share amounts or unless otherwise noted

NOTE 16—GEOGRAPHICAL INFORMATION (Continued)

Operations by Geographic Area

	Three Months Ended March 31,
	Three Months Ended June 30,				Six Months Ended June 30,
	2019		2018		2019		2018
Net Sales
Spain	$	~~816~~850	$	1,~~476~~906	$	1,665	$	3,382
United States		~~455~~532		~~1,814~~131		988		1,945
India		~~546~~319		~~426~~478		865		904
China		—		30—		—		30
Total Net Sales	$	1,~~817~~701	$	32,~~746~~515	$	3,518	$	6,261

Long–-Lived Assets by Geographic Area

	March 31, 2019		December 31, 2018
	June 30,		December 31,
	2019		2018
Long-Lived Assets
United States	$	1,~~146~~117	$	1,180
Spain		10,~~529~~499		9,707
China		—		—
Total Long-Lived Assets	$	11,616	$	10,887
Hong Kong		—		—
Total Long–Lived Assets	$	11,675	$	10,887

Foreign sales are based on the country in which the sales originated. Net sales to ~~two~~three of the Company’s major customers that exceeded 10% of the Company’s consolidated net sales for the three months ended ~~March 31~~June 30, 2019 ~~was~~were $~~822~~830. Net sales to two of the Company’s major customers that exceeded 10% of the Company’s consolidated net sales for the six months ended June 30, 2019 were $1,483. Net sales to four of the Company’s major customers that exceeded 10% of the Company’s consolidated net sales for the three months ended ~~March~~June 30, 312018 were $1,401. Net sales to two of the Company’s major customers that exceeded 10% of the Company’s consolidated net sales for the six months ended June 30, 2018 ~~was~~were $21,~~176~~444.

Accounts receivable from two customers amounted to $2,~~158~~245 as of ~~March~~June 3130, 2019 and accounts receivable from one customer amounted to $2,051 as of December 31, 2018.

NOTE 17—RELATED ~~PARTIES~~PARTY TRANSACTION

Huhui Supply Agreement

The Company’s Chinese subsidiary, Specialized Technology Resources Solar (Suzhou) Co. Ltd. (“STR China”) entered into a supply agreement (the “Huhui Supply Agreement”) dated as of December 31, 2014 with Zhangjiagang Huhui Segpv Co. Ltd ("Huhui"), a solar module manufacturer and an affiliate of Zhenfa. Pursuant to the Huhui Supply Agreement, STR China agreed to supply Huhui with the Company's encapsulant products and Huhui agreed (i) to purchase not less than 535 MW worth of encapsulants (the “Minimum Amount”) during each contract year, (ii) to pay the Company a deposit equal to 10% of the Minimum Amount, and (iii) not to purchase encapsulant products from other encapsulant manufacturers. The initial term of the Huhui Supply Agreement was for one year; however, such initial term was extended due to failure by Huhui to purchase the Minimum Amount at the end of the first year anniversary of the effective date of the Huhui Supply Agreement. The Huhui Supply Agreement further provided that Huhui’s obligations were contingent (unless otherwise provided in the agreement) upon (i) the delivery by STR China of an initial shipment of products in accordance with the specifications and (ii) the qualification of the products by Huhui during a sample production run of not less than 30 days. As of December 31, 2017, Huhui had not commenced the sample production run. The Huhui Supply Agreement automatically renewed for additional one year terms if either party failed to notify the other party at least 90 days prior to the end of the then current term that it was electing to terminate the agreement. The Company believes that the terms and conditions set forth in the Huhui Agreement at that time were fair and reasonable to the Company. The Company received $1,148 as a deposit (the “Deposit”) from Huhui during the year ended December 31, 2015, which was included in accrued liabilities on the Condensed Consolidated Balance Sheets.

1413

STR Holdings, Inc. and Subsidiaries

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS ~~(Continued)~~

(unaudited)

All amounts in thousands except share amounts, per share amounts or unless otherwise noted

NOTE 17—RELATED ~~PARTIES~~PARTY TRANSACTION (Continued)

Huhui did not complete its 30 day production run as contemplated under the Supply Agreement and on March 27, 2018, following the approval of the Company’s Special Committee of Continuing Directors, STR China entered into an agreement to terminate the Supply Agreement (the “Termination Agreement”). Pursuant to the Termination Agreement, Huhui agreed that STR China would retain the Deposit, and each of Huhui and STR China agreed to release the other from any liability or further obligations under the Supply Agreement. The Company recognized the full amount of the deposit as other income on the Condensed Consolidated Statement of Comprehensive Income (Loss) in the first quarter of 2018.

~~Huhui~~NOTE ~~agreed~~18—SUBSEQUENT that STR China would retain the Deposit, and each of Huhui and STR China agreed to release the other from any liability or further obligations under the Supply Agreement. The Company recognized the full amount of the deposit as other income on the Condensed Consolidated Statement of Comprehensive Income (Loss) in the first quarter of 2018.EVENT

15As noted herein, on January 16, 2018, the Company entered into the Original Agreements with the Purchaser having an aggregate transaction price of $6,000. In connection therewith, the Purchaser paid the Company $1,750 in the first quarter of 2018, following the Company’s satisfaction of the first performance milestone relating to the delivery of certain licensed technology to the Purchaser. The Company and the Purchaser (the “Parties”) then progressed to the satisfaction of another key milestone, qualification of the Company’s Encapsulants within Purchaser’s solar modules, before proceeding to the purchase of the Equipment.

In the fourth quarter of 2018, the Purchaser entered into negotiations with the Company aimed at converting the Original Agreements into a more customary supply arrangement, such that the Company, rather than the Purchaser, would purchase the required Equipment and produce Encapsulants for purchase by the Purchaser. During this time, the Parties substantially suspended their obligations under the Original Agreements while negotiations over terms of a new supply agreement took place.

On July 29, 2019, the Parties entered into new agreements (the “New Agreements”) which included: (i) the agreement by Purchaser of $2,000 due to the Company for work performed under the Original Agreements prior to their suspension, which was received in July 2019, (ii) the termination of the Equipment Purchase Agreement to effectively cancel any obligation of the Company to acquire Encapsulant manufacturing equipment for resale to the Purchaser, (iii) the modification of the Technology License Agreement to preserve certain rights for the Purchaser to use the proprietary Encapsulant developed for Purchaser, and (iv) the execution of a Supply Agreement (the “Supply Agreement”) for the Company’s Encapsulant.

The Supply Agreement includes a take-or-pay provision under which (i) the Purchaser must purchase a minimum quarterly volume or if not so purchased must compensate the Company for a percentage of the value of the volume shortfall, and (ii) the Company must provide a minimum supply quantity or if not so provided must compensate the Purchaser for added costs if required to obtain alternate sourcing. The Supply Agreement provides for a fixed price for Encapsulants supplied during 2020, subject to certain performance criteria, then allows price to be adjusted quarterly based on increases or decreases in the cost of raw materials. The term of the Supply Agreement is for a period of three years from commercial commencement of the new production capacity, to be set up at the Company’s expense. The term of the Supply Agreement renews annually for additional one-year periods unless cancelled by either Party. Commencement of the Supply Agreement is dependent upon completion of the qualification testing of the Encapsulant, the Company’s purchase and installation of equipment to produce the Encapsulant, and an initial-ramp up period. Assuming the satisfaction of these conditions, the Company anticipates commencing sales under the Supply Agreement within one year. The Company expects that the initial cost of the Equipment and its installation will be approximately $3,000. Based upon current pricing, which is subject to adjustment, the Company anticipates that the minimum revenue it will receive under the Supply Agreement, if the Purchaser purchases its minimum requirements under this contract, will be approximately $5,000 per quarter. The Company cannot assure that it will be able to successfully qualify its Encapsulant or timely complete the purchase and installation of the Equipment within budget, if at all. Even if successful in doing so, the Company cannot assure that it will be able to successfully manufacture the Encapsulant for the Purchaser. The Company’s failure to so succeed could have a material adverse effect its business and prospects.

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of the financial condition and results of our operations should be read together with our Condensed Consolidated Financial Statements and the related Notes to the Condensed Consolidated Financial Statements included in this Quarterly Report on Form 10-Q. This discussion contains forward-looking statements, based on current expectations and related to future events and our future financial performance, that involve risks and uncertainties. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of many factors, including those set forth under Item 1A,—Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2018.

Forward-Looking Statements

This Quarterly Report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to inherent risks and uncertainties. These forward-looking statements present our current expectations and projections relating to our financial condition, results of operations, plans, objectives, future performance and business and are based on assumptions that we have made in light of our industrial experience and perceptions of historical trends, current conditions, expected future developments and other factors management believes are appropriate under the circumstances. However, these forward-looking statements are not guarantees of future performance or financial or operating results. Forward-looking statements include, but are not limited to, the statements regarding the following: (1) incurring substantial losses for the foreseeable future, ability to achieve or sustain profitability in the future and our ability to continue as a going concern; (2) the potential impact of pursuing strategic alternatives, restructuring our business to align with our customers’ geography and our investment in and pursuit of new market opportunities in film packaging products; (3) our historical reliance on a single product line and our pursuit of new market opportunities; (4) ~~the ability to successfully complete our investment in Spain on a timely basis or within budget, if at all, or~~ that we will be able to achieve our anticipated revenue, earnings or payback from the production of packaging products; (5) that we will receive the required approvals to complete the sale of our facility in Johor, Malaysia on a timely basis, if at all; (6) our ~~securing~~ securing net sales to new customers, growing net sales to existing key customers and increasing our market share; (7) customer ~~concentration~~ concentration in our business and our relationships with and dependence on key customers; (8) the outsourcing arrangements and reliance on third parties for the manufacture of a portion of our encapsulants; (9) technological changes in the solar energy industry or our failure to develop and introduce or integrate new technologies could render our encapsulants uncompetitive or obsolete; (10) competition; (11) excess capacity in the solar supply chain; (12) demand for solar energy in general and solar modules in particular; (13) our operations in India and our assets in India and China being subject to significant ~~political~~ political and economic uncertainties; (14) limited legal recourse under the laws of India and China if disputes arise; (15) our ability to adequately protect our intellectual property, particularly during the outsource manufacturing of our products; (16) our lack of credit facility and our inability to obtain credit; (17) a significant reduction or elimination of government subsidies and economic incentives or a change in government policies that promote the use of solar energy; (18) volatility in commodity costs; (19) our customers’ financial profile causing additional credit risk on our accounts receivable; (20) our dependence on a limited number of third-party suppliers for raw materials for our encapsulants and other significant materials used in our process; (21) potential product performance matters and product liability; (22) our substantial international operations ~~and shift of business focus to India~~; (23) the impact of changes in foreign currency exchange rates on financial results, and the geographic distribution of revenues; (24) losses of financial incentives from government bodies in certain foreign jurisdictions; (25) our ability to ~~enforce~~perform ~~the~~our ~~equipment~~supply ~~purchase~~ agreement and ~~related~~ modified-technology license agreement~~, or~~ with our client; (26) that we will be able to ~~negotiate~~obtain the afunding ~~new~~for ~~arrangement~~the ~~with~~loan ~~that~~we ~~customer~~have been preliminary approved for from the Spain Ministry of Industry, ifCommerce atand ~~all~~Tourism; and (2627) the other risks and uncertainties described under “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and in subsequent periodic reports on Form 10-K, 10-Q and 8-K. You are urged to carefully review and consider the disclosure found in our filings, which are available on http://www.sec.gov or http://www.strsolar.com. Should one or more of these risks or uncertainties materialize, or should any of these assumptions prove to be incorrect, actual results may vary materially from those projected in these forward-looking statements. We undertake no obligation to publicly update any forward-looking statement contained in this Quarterly Report, whether as a result of new information, future developments or otherwise, except as may be required by law.

Overview

STR Holdings, Inc. and its subsidiaries (“we”, “us”, “our” or the “Company”) commenced operations in 1944 as a plastics and industrial materials research and development company. Based upon our expertise in polymer science, we evolved into a global provider of encapsulants to the solar industry. Our pioneering background in plastics also served as the foundation for a number of other plastics products we have manufactured over the years and led to our recent entrance into the high-end food packaging business.

1615

We were the first to develop ethylene-vinyl acetate (“EVA”) based encapsulants for use in commercial solar module manufacturing. Our initial development effort was conducted while under contract to the predecessor of the U.S. Department of Energy in the 1970s. Since that time, we have expanded our solar encapsulant business by investing in research and development and global production capacity.

Recent Developments

Liquidity Needs. We continue to incur substantial losses. We incurred net losses of $25.94 million for the ~~three~~six months ended ~~March~~June 3130, 2019 and $5.8 million for the year ended December 31, 2018. As of ~~March~~June 3130, 2019, our principal source of liquidity was $52.50 million of cash. In addition, our credit facilities are limited to our factoring arrangement in Spain and a €2.0 million economic development loan received in March 2019 from the regional government of Asturias, Spain. Unless and until our operating results improve, we do not expect that we will be able to obtain traditional bank debt. Furthermore, tight credit in the solar manufacturing industry may delay or prevent our customers from securing funding adequate to operate their businesses and purchase our products and could lead to an increase in our bad debt levels. We have recently entered into an agreement for the sale of our Johor, Malaysia facility for RM22.5 million (approximately $5.43 million, after realtor fees, as of ~~March~~June 3130, 2019). The sale is subject to customary closing conditions, including the timely approval of the sale by the Johor Port Authority, and we cannot assure that we will be able to obtain the requisite approvals or that the sale will take place on a timely basis, if at all. IfOur weSpanish dosubsidiary, ~~not~~Specialized ~~generate~~Technology ~~sufficient~~Resources ~~cash flows from operations or obtain~~España, ~~alternative~~S.A.U. or(“STR ~~additional~~Spain”), ~~sources~~has ofreceived ~~capital~~preliminary toapproval ~~fund~~for ~~operations,~~a weloan ~~will~~of ~~not~~approximately ~~have~~€2.6 ~~sufficient~~million ~~liquidity~~from tothe ~~satisfy~~Spain Ministry ~~operating~~of ~~expenses~~Industry, ~~capital~~ ~~expenditures~~Commerce and ~~other cash needs~~Tourism. ~~This~~If ~~raises~~funding ~~substantial~~is ~~doubt~~received ~~about~~STR ~~our~~Spain ~~ability~~expects to ~~continue~~use asthe aloan ~~going~~proceeds ~~concern. If we are unable~~ to ~~timely~~help ~~complete~~finance the ~~sale of our Malaysia facility or execute our strategic plans described in further detail herein,~~ ~~our~~launch ~~liquidity~~ and ~~capital~~operation ~~resources~~of ~~will~~its befood ~~adversely~~packaging ~~affected~~products ~~and we may wind down or cease any or all of our operations~~business. ~~Any wind down or dissolution may be a lengthy~~However, ~~complex and costly process and, in such event,~~ there can be no ~~assurance~~guarantee that ~~there~~ the funding will be ~~any~~received on ~~funds~~favorable ~~available~~terms, ~~for~~or ~~distribution~~at ~~to stockholders~~all.

~~India~~If ~~Tolling~~we ~~Plan.~~do Atnot ~~the~~generate ~~beginning~~sufficient ofcash ~~2017,~~flows ~~our~~from ~~manufacturing~~ operations inor ~~Asia~~obtain alternative ~~were~~or ~~based~~additional insources ~~China. A review~~ of ~~our~~capital ~~production~~to infund ~~China~~operations, ~~revealed~~we ~~that~~will ~~our~~not ~~sales~~have ~~volume~~sufficient ~~was~~liquidity ~~shifting~~ to ~~customers in~~satisfy ~~India.~~operating Asexpenses, capital aexpenditures ~~result,~~and weother ~~decided~~cash toneeds. ~~wind~~This ~~down~~raises ~~our~~substantial ~~manufacturing~~doubt ~~operations~~about inour ~~China~~ability into ~~2017~~continue ~~and~~as ~~entered~~a ~~into~~going anconcern. ~~agreement~~If ~~with~~we aare ~~tolling~~unable ~~partner~~to intimely ~~India.~~complete By the ~~close~~sale of ~~2017,~~our weMalaysia ~~effectively~~facility ~~completed~~or ~~the~~execute ~~wind~~our ~~down~~strategic ~~process~~plans described in ~~China,~~further ~~with~~detail ~~only~~herein, our aliquidity ~~small~~and ~~administrative team~~capital ~~remaining~~resources inwill anbe ~~office~~adversely ~~under~~affected aand ~~short-term~~we ~~lease,~~may ~~and~~wind ~~commenced~~down ~~tolling~~or ~~operations~~cease inany ~~India.~~or Weall ~~sold~~of our ~~undamaged~~operations. ~~production~~Any ~~line~~wind ~~from~~down ~~STR~~or ~~China~~dissolution tomay ~~this~~be ~~tolling~~a ~~partner~~lengthy, complex and incostly ~~2018~~process weand, ~~sold~~in ansuch ~~additional~~event, ~~production~~there ~~line~~can tobe ~~our~~no ~~tolling~~assurance ~~partner~~that ~~to further~~there ~~increase~~will ~~its~~be ~~manufacturing~~any ~~capacity~~funds inavailable ~~India.~~for ~~The~~distribution ~~line~~to ~~became operational at the end of the third quarter of 2018~~stockholders.

Supply Agreement and Technology License Agreement. As previously disclosed, on January 16, 2018, we entered into an Equipment Purchase Agreement and a Technology License Agreement (together, the “Original Agreements”) with a manufacturer of solar photovoltaic modules (the “Purchaser”) having an aggregate transaction price of $6.0 million. Under the Equipment Purchase Agreement, we agreed to purchase from a third party specialized equipment (the “Equipment”) for the production of one of our proprietary encapsulants (the “Encapsulant”), resell the Equipment to the Purchaser, install the Equipment at a facility of the Purchaser and train the Purchaser’s personnel in the Equipment’s use. Under the Technology License Agreement, we granted the Purchaser the right to use the formula for the Encapsulant and certain of our production techniques to make or have made the Encapsulant for use in photovoltaic (PV) modules manufactured by the Purchaser. In connection therewith, the Purchaser paid us $1.8 million in the first quarter of 2018, following our satisfaction of the first performance milestone relating to the delivery of certain licensed technology to the Purchaser. We and the Purchaser (the “Parties”) then progressed to the satisfaction of another key milestone, qualification of our Encapsulants within Purchaser’s solar modules, before proceeding to the purchase of the Equipment.

In the fourth quarter of 2018, the Purchaser entered into negotiations with us aimed at converting the Original Agreements into a more customary supply arrangement, such that we, rather than the Purchaser, would purchase the required Equipment and produce Encapsulants for purchase by the Purchaser. During this time, the Parties substantially suspended their obligations under the Original Agreements while negotiations over terms of a new supply agreement took place.

On July 29, 2019, the Parties entered into new agreements (the “New Agreements”) which included: (i) the agreement by Purchaser of $2.0 million due to us for work performed under the Original Agreements prior to their suspension, which was received in July 2019, (ii) the termination of the Equipment Purchase Agreement to effectively cancel any of our obligations to acquire Encapsulant manufacturing equipment for resale to the Purchaser, (iii) the modification of the Technology License Agreement to preserve certain rights for the Purchaser to use the proprietary Encapsulant developed for Purchaser, and (iv) the execution of a Supply Agreement (the “Supply Agreement”) for our Encapsulant.

The Supply Agreement includes a take-or-pay provision under which (i) the Purchaser must purchase a minimum quarterly volume or if not so purchased must compensate us for a percentage of the value of the volume shortfall, and (ii) we must provide a minimum supply quantity or if not so provided must compensate the Purchaser for added costs if required to obtain alternate sourcing. The Supply Agreement provides for a fixed price for Encapsulants supplied during 2020, subject to certain performance criteria, then allows price to be adjusted quarterly based on increases or decreases in the cost of raw materials. The term of the Supply Agreement is for a period of three years from commercial commencement of the new production capacity, to be set up at our expense. The term of the Supply Agreement renews annually for additional one-year periods unless cancelled by either Party. Commencement of the Supply Agreement is dependent upon completion of the qualification testing of the Encapsulant, our purchase and installation of equipment to produce the Encapsulant, and an initial ramp up period. Assuming the satisfaction of these conditions, we anticipate commencing sales under the Supply Agreement within one year.

We expect that the initial cost of the Equipment and its installation will be $3.0 million. Based upon current pricing, which is subject to adjustment, we anticipate that the minimum revenue we will receive under the Supply Agreement, if the Purchaser purchases its minimum requirements under this contract, will be approximately $5.0 million per quarter. We cannot assure that we will be able to successfully qualify our Encapsulant or timely complete the purchase and installation of the Equipment within budget, if at all. Even if successful in doing so, we cannot assure that we will be able to successfully manufacture the Encapsulant for the Purchaser. Our failure to so succeed could have a material adverse effect our business and prospects.

India Tolling Plan. At the beginning of 2017, our manufacturing operations in Asia were based in China. A review of our production records in China revealed that our sales volume had been shifting to customers in India. As a result of this shift, and a fire that affected our China operations, we decided to wind down our manufacturing operations in China in 2017 and subsequently entered into an agreement with a tolling partner in India. By the close of 2017, we effectively completed the wind down process in China, with only a small administrative team remaining in an office under a short-term lease, and commenced tolling operations in India. We sold our undamaged production line from our Chinese subsidiary, Specialized Technology Resources Solar (Suzhou) Co. Ltd. (“STR China”), to our India tolling partner, and in 2018 we sold an additional production line to the same partner to further increase its manufacturing capacity in India. The second line became operational at the end of the third quarter of 2018.

Our approach to the solar business in India was deliberately “capital lite” to avoid putting STR-owned physical assets at undue risk, which is why we elected to work through a tolling partner rather than set up our own factory in India. The Indian solar market faces intense pricing pressure from Chinese imports, as is the case in nearly all global solar markets, and is therefore subject to the associated risk that domestic manufacturers are overrun by foreign competition. While India recently instituted a 25% safeguard duty on Chinese and Malaysian solar imports, the benefit to domestic manufacturers may not be enough to counteract the entrenched foreign competition.

The competitive conditions prevalent in the Indian solar market have resulted in slow payment for STR products from Indian manufacturers and credit risk that we are presently unwilling to accept. Along with this economic reality, and also because of our unwillingness to accept orders on uncertain credit terms, our tolling partner has informed us that they are no longer interested in cooperating with STR and intends to pursue the local market with their own line of solar products.

Given this backdrop, we have made the decision to unwind our tolling partnership and business in India and are presently working with our former partner to reconcile all related accounts including the collection of outstanding accounts receivable and the settlement of amounts owed by such former tolling partner to STR for equipment and inventory.

We continue to reorganize our business to better align with customer geography, to reduce the cash burn related to unprofitable locations, to convert assets to cash for potential redeployment into more profitable endeavors and possible business opportunities and to evaluate other strategic alternatives. We cannot assure that any of these efforts will be successful.

High-End Food Packaging. In the fourth quarter of 2017, we initiated a significant investment through our wholly-owned subsidiary in Spain to enter the high-end food packaging business. This investment, which leverages our plastics expertise, includes the purchase of new, state-of-the-art plastics processing equipment and related building improvements along with the addition of experienced staff to pursue manufacturing and sales of high-end food packaging products. This project was supported in part by insurance proceeds we received for damage to our plastic manufacturing equipment that occurred in our China manufacturing facility in 2017. These insurance proceeds were available to the Company only if we invested in new plastics manufacturing equipment. We were advised by our insurer that our investment qualified for reimbursement under the terms of our policy and have received from them payments totaling approximately $2.6 million. Of this reimbursement, $0.8 million was received in October 2017 and $1.8 million was received during 2018. To further support this project, in March 2019, we obtained a €2.0 million loan from the Regional Promotion Society (“SRP”), an agency of the government of Asturias, Spain. By the close of 2018, we had substantially completed the necessary renovations to one of our buildings in Asturias, Spain, including the construction of a tower required to accommodate our new equipment, as well as the installation and interconnection of a new, state-of-the-art multi-layer blown film extrusion line. We expect this facility and equipment to allow us to begin to manufacture competitive barrier film structures for the food packaging industry in the second quarter of 2019. As of the date of this report, the new line has been installed and placed into operation, and initial trials of fully formulated, multi-layer barrier films have been completed. The food packaging business is highly competitive, having market participants with substantially more ~~resources~~ resources and experience than us. We ~~will~~are be a new entrant in this market, ~~and~~face wechallenges in loading the equipment with sufficient orders and cannot assure that we will be successful in this new endeavor.

~~Equipment~~This ~~Purchase~~project ~~Agreement~~was ~~and~~supported ~~Technology~~in ~~License~~part ~~Agreement~~by insurance proceeds we received for damage to our plastic manufacturing equipment that occurred in our China manufacturing facility in 2017. These insurance proceeds Onwere ~~January~~available 16to the Company only if we invested in new plastics manufacturing equipment. We were advised by our insurer that our investment qualified for reimbursement under the terms of our policy and have received from them payments totaling approximately $2.6 million. Of this reimbursement, $0.8 million was received in October 2017 and $1.8 million was received during 2018. To further support this project, in March 2019, we ~~entered~~obtained ~~into~~a €2.0 million loan from the Regional Promotion Society (“SRP”), an ~~equipment~~agency ~~purchase~~of ~~agreement~~the government of Asturias, Spain. In addition, and as noted above, STR Spain has received preliminary approval for a ~~technology~~loan ~~license~~of ~~agreement~~approximately ~~(together~~€2.6 million from the Spain Ministry of Industry, Commerce and Tourism which, if funding is received, we expect to use to help finance the ~~“Agreements”)~~launch and operation of its food packaging products business. By the close of 2018, we had ~~with~~substantially completed the necessary renovations to one of our buildings in Asturias, Spain, including the construction of a ~~manufacturer~~tower required to accommodate our new equipment, as well as the installation and interconnection of ~~solar~~a ~~photovoltaic~~new, ~~(PV)~~state-of-the-art ~~modules~~multi-layer blown (film extrusion line. This facility and equipment is now fully operational and ready for scale-up for the ~~“Purchaser”)~~production of barrier film structures for the food packaging industry. During the last quarter, we have finalized the development of multiple competitive film products, completed and passed the compulsory food safety testing, successfully made samples of each product type for distribution to prospective customers and manufactured our first small production orders, which have reportedly run well on our customer’s very high-speed food packaging equipment. Since installation, we have been focused on qualifying products and marketing and we have not received any significant orders to date.

~~Under~~Changes in the ~~equipment~~U.S. ~~purchase~~Solar ~~agreement~~Landscape. We believe that recent changes in U.S. Trade Policy, weincluding ~~agreed~~tariffs toimposed ~~purchase~~on ~~from a~~solar ~~third~~panels ~~party~~and ~~specialized~~encapsulants, ~~equipment~~under ~~(the~~Section ~~“Equipment”)~~301 ~~for~~of the ~~production~~U.S. Trade Act of ~~one~~1974, ofin ~~our~~combination ~~proprietary~~with ~~encapsulants~~a ~~(the “Encapsulant”),~~reduction ~~resell~~of the ~~Equipment~~corporate income tax rate to 21% under the ~~Purchaser,~~Tax ~~install~~Cuts ~~the~~and ~~Equipment~~Jobs atAct (“TCJA”), have resulted in a ~~facility~~more ofattractive ~~the~~business ~~Purchaser~~climate ~~and~~for ~~train Purchaser~~solar ~~personnel~~manufacturing in the ~~Equipment’s~~United ~~use~~States. ~~Under~~We ~~the~~have ~~technology~~experienced ~~license~~a ~~agreement,~~four-fold increase wein ~~granted~~encapsulant ~~the~~sales ~~Purchaser~~from our CT location for the ~~right~~six months ending June 30, 2019, as compared to ~~use~~ the ~~formula~~corresponding ~~for~~prior-year period. ~~the~~We ~~Encapsulant~~attribute ~~and~~this ~~certain~~increase ofto ~~our~~more domestic production ~~techniques~~of tosolar ~~make~~panels ordriven ~~have~~in ~~made~~part ~~the~~by ~~Encapsulant~~tariffs ~~for~~on ~~use~~imports inand PVthe more ~~modules~~internationally ~~manufactured~~competitive bycorporate ~~the~~tax ~~Purchaser~~rate. ~~The~~Aside ~~license~~from ~~granted~~those drivers, STR has continued to ~~the~~work ~~Purchaser~~with ~~pursuant~~prospective customers to ~~the~~evaluate ~~technology~~new ~~license~~proprietary ~~agreement~~encapsulant isproducts ~~exclusive with~~and ~~respect~~anticipates tothat ~~specified~~these ~~types~~efforts ofmay PValso ~~modules~~translate ~~manufactured~~into byadditional ~~the~~demand ~~Purchaser,~~moving forward if and ~~nonexclusive~~when asthese tonew ~~all~~products ~~other~~are ~~types~~ultimately ofqualified PVand ~~modules~~selected. ~~The~~ ~~Purchaser~~Tariffs, ~~may~~and ~~also~~tax ~~sublicense~~rates ~~its rights~~ under the ~~technology~~TCJA, ~~license~~may ~~agreement~~change and todisrupt ~~licensees~~the trajectory of ~~its~~recent PVgains ~~module~~in ~~manufacturing processes~~sales from our CT location or otherwise deteriorate current conditions.

Under the equipment purchase agreements, the Purchaser agreed to pay us up to an aggregate of $6.0 million. Billing and payment under the Agreements follows a schedule involving certain milestones relating to the qualification of the Encapsulant and installation, acceptance and operation of the Equipment. We received the initial payment of $1.8 million during the first quarter of 2018. For revenue recognition purposes under Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers” (ASC 606), $1.8 million was recorded as revenue during the first quarter of 2018 as initial performance obligations were satisfied. See Note 2 to the Condensed Consolidated Financial Statements.

The next milestone under the equipment purchase agreement, for which an additional $1.8 million would be due, is the completion of product qualification for the product being licensed. We have completed our testing of the product. However, the Purchaser is in default of its obligation under the equipment purchase agreement to diligently and in good faith pursue completion of the production qualification within 120 days of receipt of the product sample, and has entered into discussions with us to modify the Agreements. Such discussions include a proposal for the parties to enter into a more traditional customer relationship, whereby we would serve as an encapsulant manufacturer and supplier to the Purchaser. Such arrangement would also require successful completion of product qualification. We cannot assure that the parties will enter into an alternative arrangement, or that, if entered into, such alternative arrangement will be on terms favorable to us. We also cannot assure that we will be able to meet the Purchaser’s product qualification standards under the original or any modified arrangement. If we are not otherwise successful in negotiating an alternative arrangement, and the Purchaser does not complete its product qualification or otherwise fulfill its obligations under the Agreements, we intend to explore our legal remedies against the Purchaser. Due to the inherent uncertainties in pursing any such remedies, and the associated costs, expense and diversion of management time and resources, any ongoing dispute with the Purchaser could adversely affect our results of operations and cash flow.

2014 Transaction with Zhenfa

In 2014, we entered into certain definitive agreements with Zhenfa Energy Group Co., Ltd., a Chinese limited liability company (“Zhenfa”), and its indirect wholly owned subsidiary, Zhen Fa New Energy (U.S.) Co., Ltd., a Nevada corporation (“Zhenfa U.S.”).

Purchase Agreement.

On August 11, 2014, we entered into a Stock Purchase Agreement (the “Purchase Agreement”) with Zhenfa U.S., pursuant to which Zhenfa U.S. acquired approximately 51% of our then outstanding shares of common stock on December 15, 2014 (the “Closing Date”).

Sales Service Agreement.

In connection with the execution of the Purchase Agreement, Specialized Technology Resources, Inc., our wholly owned subsidiary, entered into a sales service agreement (the "Sales Service Agreement") with Zhenfa, whereby Zhenfa agreed, among other things, to assist us in a number of endeavors, including, without limitation, marketing and selling our products in China, acquiring local raw materials, hiring and training personnel in China, and complying with Chinese law. The Sales Service Agreement became effective on the date of Closing, for an initial term of two years, and automatically renews for one year periods unless terminated earlier. The Sales Service Agreement may also be terminated by either party at such time as Zhenfa and its affiliates own less than 10% of our outstanding common stock.

As we have substantially discontinued operations in China, Zhenfa is not currently providing us with any material services under this agreement. Any activities with Zhenfa under the Sales Service Agreement are subject to the oversight of our Special Committee of Continuing Directors.

CRITICAL ACCOUNTING POLICIES

Our discussion and analysis of our financial condition and results of operations are based upon our interim Condensed Consolidated Financial Statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The preparation of these Condensed Consolidated Financial Statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, net sales and expenses, and related disclosures of contingent assets and liabilities. We continually evaluate our estimates, including those related to bad debts, valuation of inventory, long-lived assets, product performance matters, income taxes, stock–based compensation and deferred tax assets and liabilities. We base our estimates on historical experience and various other assumptions that we believe to be reasonable under the circumstances. Actual results may differ from these estimates. The accounting policies we believe to be most critical to understand our financial results and condition and that require complex and subjective management judgments are discussed in “Management’s Discussion and Analysis of Financial Condition and Results of Operations-Critical Accounting Policies” in our Annual Report on Form 10–K filed with the Securities and Exchange Commission on March 27, 2019, as amended on April 26, 2019.

RESULTS OF OPERATIONS

Condensed Consolidated Results of Operations

The following tables set forth our condensed consolidated results of operations for the three and six months ended ~~March~~June 3130, 2019 and 2018:

	Three Months Ended March 31,
	Three Months Ended June 30,						Six Months Ended June 30,
	2019			2018			2019			2018
Net sales	$	1,~~817~~701		$	32,~~746~~515		$	3,518		$	6,261
Cost of sales		2,~~829~~613			23,~~445~~490			5,442			5,935
Gross (loss) profit		(~~1,012~~912	)		~~1,301~~(975	)		(1,924	)		326
Selling, general and administrative expenses		1,~~337~~225			1,~~692~~380			2,562			3,072
Research and development expense		~~194~~189			~~215~~190			383			405
Provision (recovery) for bad debt expense		304			(61	)
Provision for bad debt expense		486			67			790			6
Operating loss		(2,~~847~~812	)		(~~545~~2,612	)		(5,659	)		(3,157	)
Interest expense, net		(1	)		(1	)
Interest (expense) income, net		(11	)		16			(12	)		15
Other (expense) income, net		(25	)		1,020
Other (expense) income, net (Note 8)		(44	)		183			(69	)		1,203
Foreign currency transaction loss		(71	)		(56	)
Gain (loss) on disposal of fixed assets		1			(383	)		1			(383	)
(Loss) earnings from operations before income tax (benefit) expense		(2,944	)		418
Foreign currency transaction gain (loss)		71			(106	)		—			(162	)
Income tax (benefit) expense from operations		(88	)		99
Loss before income tax (benefit) expense		(2,795	)		(2,902	)		(5,739	)		(2,484	)
Net (loss) earnings from operations	$	(2,856	)	$	319
Income tax (benefit) expense		(218	)		172			(306	)		271
Net loss	$	(2,577	)	$	(3,074	)	$	(5,433	)	$	(2,755	)

Net Sales

	Three Months Ended March 31,
	Three Months Ended June 30,																Six Months Ended June 30,
	2019					2018					Change						2019					2018					Change
	Amount		% of Total Net Sales			Amount		% of Total Net Sales			Amount			%			Amount		% of Total Net Sales			Amount		% of Total Net Sales			Amount			%
Net sales	$	1,~~817~~701		100.0	%	$	32,~~746~~515		100.0	%	$	(~~1,929~~814	)		(5132.54	)%	$	3,518		100.0	%	$	6,261		100.0	%	$	(2,743	)		(43.8	)%

The decrease in net sales for the three months ended ~~March~~June 3130, 2019 compared to the corresponding period in 2018 was driven by ~~recognition~~an ofapproximate ~~$1.8~~21% ~~million~~decrease ~~related to completed performance obligations under the equipment purchase agreement and the technology license agreement~~ in ~~2018~~sales volume combined with a ~~$0.2 million reduction in encapsulant sales. The decrease in encapsulant sales was primarily attributable to an approximate 16~~15% decrease in our average selling price (“ASP”) ~~that was partially offset by an approximate 7% increase in sales volume~~.

19The volume decline was primarily driven by a 54% decrease in Spain due to the further weakening of the European module manufacturing environment, a 31% decrease in India due to unwinding our partnership with our tolling partner there and a 100% decrease in volume in China, partially offset by volume increases to customers in the U.S.

The ~~volume~~decrease ~~improvement~~in ~~was~~net ~~primarily~~sales ~~driven~~for bythe ~~significant~~six ~~volume increases~~months inended ~~India~~June ~~through~~30, ~~our~~2019 compared ~~tolling~~to ~~partner~~the ~~and~~corresponding period in ~~the~~2018 ~~U.S.,~~was ~~partially~~driven ~~offset~~ by a ~~decrease~~$1.0 inmillion ~~volume~~reduction in ~~Spain~~encapsulant ~~primarily~~sales ~~due~~combined with $1.8 million related to ~~the~~completed ~~further~~performance ~~weakening~~obligations ofunder the ~~European~~Original ~~module~~Agreements ~~manufacturing~~that ~~environment~~was recognized in 2018. The decrease in ~~ASP~~encapsulant sales was primarily attributable to an approximate 8% decrease in sales volume, as well as a 15% decrease in our ASP, relating ~~lower~~to our discontinuance of lower-priced sales in ~~India~~China.

The volume decline was primarily driven by a 49% volume decrease in Spain and a 100% volume decrease in China, partially offset by sales to customers in the U.S.

Cost of Sales

	Three Months Ended March 31,
	Three Months Ended June 30,																Six Months Ended June 30,
	2019					2018					Change						2019					2018					Change
	Amount		% of Total Net Sales			Amount		% of Total Net Sales			Amount			%			Amount		% of Total Net Sales			Amount		% of Total Net Sales			Amount			%
Cost of sales	$	2,~~829~~613		~~155~~153.76	%	$	23,~~445~~490		65138.38	%	$	~~384~~(807	)		15(25.71	)%	$	5,442		154.7	%	$	5,935		94.8	%	$	(493	)		(8.3	)%

The increase in our cost of sales for the three months ended March 31, 2019 compared to the corresponding period in 2018 was primarily driven by a 7% increase in encapsulant sales volume combined with an approximate 18% increase in raw material cost per unit. The higher raw material cost per unit was primarily driven by a 12% decrease in paperless sales mix. Direct labor decreased by $0.1 million partially attributable to the sales volume decrease in Spain. Overhead costs decreased by $0.2 million primarily due to continued cost-reduction actions.19

The decrease in our cost of sales for the three months ended June 30, 2019 compared to the corresponding period in 2018 was primarily driven by the 21% decrease in encapsulant sales volume combined with a 1% decrease in raw material cost per unit. The lower raw material cost per unit was primarily driven by a 8% decrease in resin costs, as well as a 6% decrease in paperless sales mix. Direct labor decreased by $0.4 million partially attributable to the sales volume decrease in Spain. Overhead costs decreased by $0.3 million primarily due to continued cost-reduction actions.

The decrease in our cost of sales for the six months ended June 30, 2019 compared to the corresponding period in 2018 was primarily driven by the 8% decrease in encapsulant sales volume combined with a 3% increase in raw material cost per unit. The higher raw material cost per unit was primarily driven by a 8% decrease in paperless sales mix. Direct labor decreased by $0.5 million attributable to the sales volume decrease in Spain. Overhead costs decreased by $0.4 million primarily due to continued cost-reduction actions.

Gross (Loss) Profit

	Three Months Ended March 31,
	Three Months Ended June 30,																		Six Months Ended June 30,
	2019						2018						Change						2019						2018					Change
	Amount			% of Total Net Sales			Amount			% of Total Net Sales			Amount			%			Amount			% of Total Net Sales			Amount		% of Total Net Sales			Amount			%
Gross (loss) profit	$	(~~1,012~~912	)		(5553.76	)%	$	~~1,301~~(975	)		34(38.78	)%	$	~~(2,313~~63	)		~~(177~~6.85	)%	$	(1,924	)		(54.7	)%	$	326		5.2	%	$	(2,250	)		(690.2	)%

Gross (loss), ~~profit~~ as a percentage of net sales, declined for the ~~three~~ three months ended ~~March~~June 3130, 2019 compared to the corresponding period in 2018 mainly as a result of ~~recognition~~the ofdecrease ~~$1.8~~in ~~million~~encapsulant ~~related~~sales tovolume ~~completed~~combined ~~performance~~with ~~obligations~~a ~~under~~decrease ~~the~~in ~~equipment~~paperless ~~purchase~~sales ~~agreement and the technology license agreement during 2018~~mix.

Gross (loss) profit as a percentage of net sales declined for the six months ended June 30, 2019 compared to the corresponding period in 2018 mainly as a result of recognition of $1.8 million related to completed performance obligations under the Original Agreements during 2018.

Selling, General and Administrative Expenses (“SG&A”)

	Three Months Ended March 31,
	Three Months Ended June 30,																Six Months Ended June 30,
	2019					2018					Change						2019					2018					Change
	Amount		% of Total Net Sales			Amount		% of Total Net Sales			Amount			%			Amount		% of Total Net Sales			Amount		% of Total Net Sales			Amount			%
SG&A	$	1,~~337~~225		7372.60	%	$	1,~~692~~380		4554.29	%	$	(~~355~~155	)		(2111.02	)%	$	2,562		72.8	%	$	3,072		49.1	%	$	(510	)		(16.6	)%

SG&A decreased by $0.42 million for the three months ended ~~March 31,~~June 30, 2019 compared to 2018. This decrease was primarily driven by a $0.21 million ~~decrease~~reduction in ~~professional fees, a $0.1 million decrease in~~ non-cash stock compensation expense and a $0.1 million decrease in restructuring ~~charges.~~expense

SG&A decreased by $0.5 million for the six months ended June 30, 2019 compared to 2018. This decrease was primarily driven by a $0.2 million reduction in non-cash stock compensation expense, a $0.1 million decrease in restructuring expense and a $0.1 million decrease in professional fees.

Research and Development Expense (“R&D”)

	Three Months Ended March 31,
	Three Months Ended June 30,																Six Months Ended June 30,
	2019					2018					Change						2019					2018					Change
	Amount		% of Total Net Sales			Amount		% of Total Net Sales			Amount			%			Amount		% of Total Net Sales			Amount		% of Total Net Sales			Amount			%
Research and development expense	$	194		10.7	%	$	215		5.7	%	$	(21	)		(9.8	)%
R&D	$	189		11.1	%	$	190		7.6	%	$	(1	)		(0.5	)%	$	383		10.9	%	$	405		6.5	%	$	(22	)		(5.4	)%

Research and development expense decreased by less than $0.1 million for the three and six months ended ~~March~~June 3130, 2019 compared to 2018, mainly due to activities related to our entrance into the packaging business in 2018.

Provision ~~(recovery)~~ for Bad Debt Expense

	Three Months Ended March 31,
	Three Months Ended June 30,																Six Months Ended June 30,
	2019					2018						Change					2019					2018					Change
	Amount		% of Total Net Sales			Amount			% of Total Net Sales			Amount		%			Amount		% of Total Net Sales			Amount		% of Total Net Sales			Amount		%
Provision (recovery) for bad debt expense	$	304		16.7	%	$	(61	)		(1.6	)%	$	365		598.4	%
Provision for bad debt expense	$	486		28.6	%	$	67			2..7	%	$	419		625.4	%	$	790		22.5	%	$	6		0.1	%	$	784		13,066.7	%

The provision for bad debt expense for the three and six months ended ~~March~~ 31June 30, 2019 primarily related to the aging of accounts receivable under our policy, primarily in the U.S and India.

The recovery for bad debt expense recorded during the three months ended ~~March~~June 3130, 2018 primarily related to receiving cash for previously aged accounts receivable that were reserved for under our policy, primarily in China. The provision for bad debt expense recorded during the six months ended June 30, 2018 primarily related the aging of accounts receivable under our policy, primarily in the U.S. The provision was partially offset by receiving cash for previously aged accounts receivable that were reserved for under our policy, primarily in China.

Other (Expense) Income, net

	Three Months Ended March 31,
	Three Months Ended June 30,																	Six Months Ended June 30,
	2019						2018					Change						2019						2018					Change
	Amount			% of Total Net Sales			Amount		% of Total Net Sales			Amount			%			Amount			% of Total Net Sales			Amount		% of Total Net Sales			Amount			%
Other (expense) income	$	(25	)		1.4	%	$	1,020		27.2	%	$	(1,045	)		(102.5	)%
Other (expense) income, net	$	(44	)		(2.6	)%	$	183		7.3	%	$	(227	)		(124.0	)%	$	(69	)		(2.0	)%	$	1,203		19.2	%	$	(1,272	)		(105.7	)%

On March 27, 2018, following the approval of the Company’s Special Committee of Continuing Directors, STR China entered into an agreement to terminate ~~the~~its Huhui Supply Agreement (the “Termination Agreement”) with Zhangjianang Huhui Segpy Co. Ltd (“Huhui”). In connection with the supply agreement, Huhui had provided us with an approximately $1.1 million deposit during the year ended December 31, 2015. Pursuant to the Termination Agreement, Huhui agreed that STR China would retain the deposit, and each of Huhui and STR China agreed to release the other from any liability or further obligations under the Supply Agreement. As a result of the Termination Agreement, we recorded other income of $1.0 million during the first ~~quarter~~six months of 2018.

Foreign Currency Transaction (Loss) Gain

	Three Months Ended March 31,
	Three Months Ended June 30,																		Six Months Ended June 30,
	2019						2018						Change						2019					2018						Change
	Amount			% of Total Net Sales			Amount			% of Total Net Sales			Amount			%			Amount		% of Total Net Sales			Amount			% of Total Net Sales			Amount		%
Foreign currency transaction loss	$	(71	)		(3.9	)%	$	(56	)		(1.5	)%	$	(15	)		(26.8	)%
Foreign currency transaction (loss) gain	$	71			4.2	%	$	(106	)		(4.2	)%	$	177			167.0	%	$	—		(0.0	)%	$	(162	)		(2.6	)%	$	162		100.0	%

The foreign currency transaction impact was a ~~loss~~gain of ~~less than~~ $0.1 ~~million~~ million for the three months ended ~~March~~June 3130, 2019 ~~and~~compared ~~March~~to 31a loss of $0.1 million for the three months ended June 30, 2018. This change was primarily the result of volatility in the Euro spot exchange rate versus the U.S. dollar.

The foreign currency transaction impact was $0.0 million for the six months ended June 30, 2019 compared to a loss of $0.2 million for the six months ended June 30, 2018.

Our primary foreign currency exposures are intercompany loans, U.S. dollar cash balances in foreign locations and some U.S. dollar denominated accounts receivable at our Spain and China facilities.

Income Tax (Benefit) Expense

	Three Months Ended March 31,
	2019						2018					Change
	Amount			% of Total Net Sales			Amount		% of Total Net Sales			Amount			%
Income tax (benefit) expense	$	(88	)		(4.8	)%	$	99		2.6	%	$	(187	)		(188.9	)%

During the three months ended March 31, 2019, we recorded an income tax benefit of $0.1 million, resulting in an effective tax rate of 3.0%. This effective tax rate for the three months ended March 31, 2019 differs from the U.S. statutory tax rate primarily due to the effect of taxes on foreign earnings.

During the three months ended March 31, 2018, we recorded an income tax expense of $0.1 million, resulting in an effective tax rate of 23.7%. This effective tax rate for the three months ended March 31, 2018 differs from the U.S. statutory tax rate primarily due to the effect of taxes on foreign earnings.

Income Tax (Benefit) Expense

	Three Months Ended June 30,																	Six Months Ended June 30,
	2019						2018					Change						2019						2018					Change
	Amount			% of Total Net Sales			Amount		% of Total Net Sales			Amount			%			Amount			% of Total Net Sales			Amount		% of Total Net Sales			Amount			%
Income tax (benefit) expense	$	(218	)		(12.8	)%	$	172		6.8	%	$	(390	)		(226.7	)%	$	(306	)		(8.7	)%	$	271		4.3	%	$	(577	)		(212.9	)%

During the three and six months ended June 30, 2019, we recorded an income tax benefit of $0.2 million and $0.3 million, respectively, resulting in an effective tax rate of 7.8% and 5.3%, respectively. This effective tax rate for the three months ended June 30, 2019 differs from the U.S. statutory tax rate primarily due to the effect of taxes on foreign earnings.

During the three and six months ended June 30, 2018, we recorded an income tax expense of $0.2 million and $0.3 million, respectively, resulting in an effective tax rate of (5.9%) and (10.9%), respectively. This effective tax rate for the three months ended June 30, 2018 differs from the U.S. statutory tax rate primarily due to the effect of taxes on foreign earnings.

Cost-Reduction Actions

On March 7, 2017 we made the decision to wind down our China manufacturing operations substantially by the end of the second quarter of 2017. The decision was consistent with ongoing efforts to reorganize our business to better align with customer geography, to reduce losses related to unprofitable locations and to convert assets to cash for potential redeployment into more profitable endeavors. In connection with the restructuring, we recorded $0.1 million of severance charges during the first ~~quarter~~six months of 2017 and the first ~~quarter~~six months of 2018. The Company sold certain production and testing equipment from the China facility to its tolling partner in India during the third quarter of 2017.

In June 2018, we eliminated certain positions at our Spain facility effective June 18, 2018. We recorded $0.6 million of severance and benefits in cost of sales and $0.1 million of severance and benefits in selling, general and administrative expenses during 2018.

A roll-forward of the severance and other exit cost accrual activity iswas as follows:

	March 31, 2019		March 31, 2018
	June 30, 2019		June 30, 2018
Balance as of beginning of year	$	0.1	$	0.1
Additions		—		0.17
Reductions		—		(0.17	)
Balance as of end of period	$	0.1	$	0.1

The restructuring accrual ~~consists~~consisted of $0.1 million and $0.1 million for severance and benefits as of ~~March 31~~June 30, 2019 and 2018, respectively.

Financial Condition, Liquidity and Capital Resources

We continue to incur substantial losses. We incurred net losses of $25.94 million and $5.8 million for the ~~three~~six months ended ~~March~~June 3130, 2019 and for the year ended December 31, 2018, respectively. As As of ~~March~~June 3130, 2019, our principal source of liquidity was $52.50 million of cash, of which $0.8 million was located in jurisdictions outside of the United States. In addition, our credit facilities are limited to our factoring arrangement in Spain and a €2.0 million economic development loan received in March 2019 from the regional government of Asturias, Spain. Unless and until our operating results improve, we do not expect that we will be able to obtain traditional bank financing. Furthermore, tight credit in the solar manufacturing industry may delay or prevent our customers from securing funding adequate to operate their businesses and purchase our products and could lead to an increase in our bad debt levels. We have ~~recently~~ entered into an agreement for the sale of our Johor, Malaysia facility for RM22.5 million (approximately $5.4 3 million, after realtor fees, as of ~~March~~June 3130, 2019). The sale is subject to customary closing conditions, including the timely approval of the sale by the Johor Port Authority, and we cannot assure that we will be able to obtain the requisite approvals or that the sale will take place on a timely basis, if at all. If we are unable to timely complete the sale of our Malaysia facility, or execute our strategic plans, our liquidity and capital resources will be adversely affected and we may wind down or cease any or all of our operations. Any wind down or dissolution may be a lengthy, complex and costly process and, in such event, there can be no assurance that there will be any funds available for distribution to stockholders.

Our independent auditors have indicated in their report on our December 31, 2018 financial statements that there is substantial doubt about our ability to continue as a going concern. This “going concern” opinion indicates that the financial statements have been prepared assuming we will continue as a going concern and do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets, or the amounts and classification of liabilities that may result if planned events do not occur or do not occur timely and we do not continue as a going concern. Therefore, you should not rely on our consolidated balance sheet as an indication of the amount of proceeds that would be available to satisfy claims of creditors, and potentially be available for distribution to stockholders, in the event of liquidation. If we are unable to continue as a going concern we cannot assure that any funds will be available for distribution to stockholders.

Management has evaluated whether relevant conditions or events, considered in the aggregate, indicate that there is substantial doubt about our ability to continue as a going concern. Substantial doubt exists when conditions and events, considered in the aggregate, indicate it is probable that we will be unable to meet our obligations as they become due during the next 12 months. The assessment is based on the relevant conditions that are known or reasonably knowable as of the date of this report.

22If we do not generate sufficient cash flows from operations, complete the sale of our Malaysian facility or obtain alternative or additional sources of capital to fund operations, we will not have sufficient liquidity to satisfy operating expenses, capital expenditures and other cash needs. This raises substantial doubt about our ability to continue as a going concern.

IfOur wewholly doowned ~~not~~Spanish ~~generate~~subsidiary, ~~sufficient~~STR ~~cash~~Spain, ~~flows~~has ~~from~~a ~~operations~~factoring oragreement to ~~obtain~~sell, with recourse, certain European, U.S. and other foreign company-based receivables to Eurofactor Hispania S.A.U., who was ~~alternative~~later oracquired ~~additional~~by ~~sources~~Credit Agricole Leasing & Factoring Sucursal en España during the first quarter of ~~capital~~2017. toUnder ~~fund~~the current ~~operations~~terms of the factoring agreement, wethe ~~will~~maximum ~~not~~amount ~~have~~of ~~sufficient~~outstanding ~~liquidity~~advances at any one time is €1.5 million (approximately $1.7 million as of June 30, 2019), which is subject to ~~satisfy~~adjustment ~~operating~~based ~~expenses~~on the level of eligible receivables, restrictions ~~capital~~on ~~expenditures~~concentrations of receivables and the historical performance of the receivables sold. The annual discount rate is 2% plus EURIBOR for Euro-denominated receivables and 2% plus LIBOR for all other ~~cash~~currencies. The ~~needs~~agreement renews annually unless terminated by either party with 90 days prior written notice. ~~This~~As ~~raises~~of ~~substantial~~June ~~doubt~~30, ~~about~~2019, ~~our~~€0.2 ~~ability~~million to(approximately ~~continue~~$0.2 million as aof ~~going~~June ~~concern~~30, 2019) was outstanding, and €1.3 million (approximately $1.5 million as of June 30, 2019) was available (subject to receivables then outstanding) under the factoring agreement.

~~Our~~As ~~wholly~~noted ~~owned Spanish subsidiary~~above, ~~Specialized~~on ~~Technology~~January ~~Resources España~~10, ~~S.A.U.~~2019 ~~(“STR~~we ~~Spain”),~~entered ~~has~~into a ~~factoring~~Purchase ~~agreement to sell, with recourse, certain European, U.S.~~ and ~~other~~ ~~foreign~~Sale ~~company-based~~Agreement ~~receivables~~for toour ~~Eurofactor~~Malaysia ~~Hispania S.A.U.~~facility, ~~who~~pursuant ~~was~~to ~~later~~which ~~acquired~~we bywould ~~Credit~~sell ~~Agricole Leasing & Factoring Sucursal en España during~~ the ~~first~~facility ~~quarter~~to ~~of 2017. Under~~ the ~~current~~buyer ~~terms~~for ~~of the factoring agreement, the maximum amount of outstanding advances at any one time is €1~~RM22.5 million (approximately $15.73 million, asafter ofrealtor ~~March 31~~fees, ~~2019),~~as ~~which is subject to adjustment based on the level~~ of ~~eligible~~June ~~receivables~~30, ~~restrictions~~2019). onThe ~~concentrations~~agreement ofprovides ~~receivables~~that ~~and~~ the ~~historical~~closing ~~performance~~ of the ~~receivables~~sale ~~sold. The~~is ~~annual~~subject ~~discount~~to ~~rate~~various customary isand 2%regulatory ~~plus~~approvals ~~EURIBOR~~and ~~for~~conditions, ~~Euro-denominated~~including ~~receivables~~the ~~and~~approval 2%of ~~plus~~the ~~LIBOR~~Johor ~~for all~~Port ~~other currencies~~Authority. The agreement ~~renews~~further ~~annually~~provides that ~~unless~~if ~~terminated~~the byclosing ~~either~~does ~~party~~not ~~with~~occur 90within ~~days~~six ~~prior written notice. As of March 31~~months, ~~2019,~~either ~~€0.2~~party ~~million~~may ~~(approximately~~terminate ~~$0.2~~the ~~million as of March 31~~agreement, ~~2019)~~however ~~was~~the ~~outstanding,~~Company and ~~€1.3~~the ~~million (approximately~~buyer ~~$1.5~~agreed ~~million~~to asextend ofthe ~~March~~closing ~~31,~~window ~~2019)~~an ~~was~~additional ~~available~~six ~~(subject~~months to ~~receivables~~allow ~~then~~for ~~outstanding)~~potential ~~under~~delays in obtaining the ~~factoring~~necessary ~~agreement~~approvals.

OnIn ~~November~~the 1,fourth ~~2018~~quarter of 2017, wethe ~~received~~Company initiated a ~~non-binding~~significant investment ~~letter~~through ofSTR ~~intent~~Spain ~~from a~~to ~~potential~~enter ~~buyer~~the ~~for~~high-end ~~our~~food ~~Malaysia~~packaging ~~facility~~business. ~~for~~This ~~RM22.5~~investment, ~~million~~which ~~(approximately~~leverages ~~$5.4~~our ~~million~~plastics expertise, includes ~~after~~the ~~realtor~~purchase ~~fees~~of new, as state-of-the-art ~~March~~plastics ~~31, 2019)~~processing equipment and ~~subsequently~~related ~~entered~~building ~~into~~improvements aalong ~~Purchase~~with ~~and~~the ~~Sale~~addition of ~~Agreement~~experienced ~~with~~staff ~~this~~to ~~buyer~~pursue ~~effective~~manufacturing ~~January~~and ~~10,~~sales ~~2019.~~of ~~The~~high-end ~~agreement~~food ~~provides that~~packaging ~~the~~products. ~~closing~~We ofhave ~~the~~received ~~sale~~and isapplied ~~subject~~certain conditional insurance proceeds to ~~various~~this ~~customary~~project, ~~and~~helping ~~regulatory~~to ~~approvals~~offset ~~and~~our ~~conditions,~~net ~~including~~capital ~~the~~investment. ~~approval~~These ofinsurance proceeds were available to the ~~Johor~~Company ~~Port~~only ~~Authority~~if we invested in new plastics manufacturing equipment. ~~The~~We ~~agreement~~were ~~further~~advised ~~provides~~by our insurer that ifour ~~the~~investment qualified ~~conditions~~for toreimbursement under the ~~closing~~terms ~~are~~of ~~not~~our ~~met~~policy and, ~~the~~accordingly, ~~closing~~they ~~does not~~have ~~occur~~paid ~~within~~our ~~six~~U.S. ~~months,~~entity ~~either~~the ~~party~~amount ~~may~~of ~~terminate~~$0.8 ~~the~~million in ~~agreement~~October 2017, ~~although~~to cover the ~~Company~~cost ~~and~~of the ~~buyer~~deposit ~~expect~~for tothe ~~sign~~primary ancapital ~~amendment to~~equipment. ~~extend~~Our ~~the~~U.S. ~~closing~~entity ~~window~~also received an additional $1.8 ~~six~~million ~~months~~reimbursement toduring ~~allow~~2018 ~~for~~as ~~potential~~we ~~delays~~continued into ~~obtaining~~make qualifying capital investment under the ~~necessary~~packaging ~~approvals~~project.

In the fourth quarter of 2017, the Company initiated a significant investment through STR Spain to enter the high-end food packaging business. This ongoing investment, which leverages our plastics expertise, includes the purchase of new, state-of-the-art plastics processing equipment and related building improvements along with the addition of experienced staff to pursue manufacturing and sales of high-end food packaging products. We have received and applied certain conditional insurance proceeds to this project, helping to offset our net capital investment. These insurance proceeds were available to the Company only if we invested in new plastics manufacturing equipment. We were advised by our insurer that our investment qualified for reimbursement under the terms of our policy and, accordingly, they have paid our U.S. entity the amount of $0.8 million in October 2017, to cover the cost of the deposit for the primary capital equipment. Our U.S. entity also received an additional $1.8 million reimbursement during 2018 as we continued to make qualifying capital investment under the packaging project. On March 13, 2019, STR Spain also obtained a €2.0 million ($2.2 3 million as of ~~March~~June 3130, 2019) loan (the “STR Spain Loan”) from the regional government of Asturias, Spain to further support our entry into the ~~project~~high-end food packaging business. STR Spain is required to use the loan proceeds to help finance the launch and operation of its food packaging products business. The STR Spain Loan matures on December 31, 2025, with principal due and payable in equal quarterly installments of €0.1 million each, commencing on March 31, 2021. Interest, which is payable quarterly in arrears, accrues at the annual EURIBOR rate (as such term is defined in the loan agreement) plus an applicable margin. During the first two years, the applicable margin is 2%, and thereafter increases by 1% per year until the applicable margin is 5% in the fifth year of the loan. The loan may be prepaid at any time without premium or penalty. The loan is secured by a mortgage of STR Spain’s business and certain facilities, and contains customary covenants, including a covenant prohibiting STR Spain from making distributions to us, as sole shareholder, without the prior approval of the lender. In connection with the STR Spain Loan, we have also agreed to provide STR Spain with resources to support the loan and the continuity of the packaging initiative. In addition, STR Spain has received preliminary approval for an additional loan of approximately €2.6 million from the Spain Ministry of Industry, Commerce and Tourism which, if funded, we expect to use to help finance the launch and operation of its food packaging products business. However, there can be no guarantee that the funding will be received on favorable terms, or at all.

We remain open to exploring possible business opportunities, alternate geographic markets, as well as other strategic alternatives. We cannot assure that we will be able to successfully pursue any such potential opportunities. If we are successful in pursuing any such opportunities, we may be required to expend significant funds, incur debt or other obligations or issue additional securities, any of which could significantly dilute our current stockholders and may negatively affect our operating results and financial condition. We cannot assure that any such strategic opportunities or related transactions, or any financing in connection therewith, would be available on favorable terms, if at all, or that we will realize any anticipated benefits from any such transactions that we complete. In the event that we are not successful in restructuring our business or pursuing other strategic opportunities, we also intend to consider alternatives, including, without limitation, the acquisition of another business, the divestiture of all or certain of our assets, joint ventures and other transactions outside the ordinary course of business.

Our cash and cash equivalents balance is located in the following geographies (dollars in thousands):

	March 31, 2019
	June 30, 2019
United States	$	21,~~674~~219
Spain		~~2,372~~376
Malaysia		100
China		213
China		305
Hong Kong		96
Hong Kong		85
Malaysia		64
India		1
Consolidated	$	51,~~536~~969

~~Due~~As noted above, due to, among other things, the difficulty repatriating cash to the U.S., ~~among other factors,~~ we may have limited access to the $0.32 million of cash located in China for use outside the country. In addition, the STR Spain Loan prohibits STR Spain from distributing cash to us without the consent of the lender. In 2017 we applied for, and received approval for, a reduction of the registered capital associated with STR China, enabling us to move $5.0 million out of China. In 2018, we received a further reduction of $3.0 million that was used to settle intercompany loans ultimately flowing back to the United States.

We do not permanently re-invest our Malaysia subsidiary’s earnings. Based upon the Malaysia subsidiary’s liabilities to us, we expect the undistributed earnings of our Malaysia subsidiary will be repatriated to the U.S. in a tax-free manner. We do not permanently re-invest our Spain earnings, so this cash balance is available for dividend repatriation (less any applicable withholding taxes). We have not elected to permanently re-invest our Hong Kong and China earnings and plan to utilize our cash located in Hong Kong and China to fund working capital requirements and wind- down costs. Our goal is to achieve and maintain self-sufficiency in each of our manufacturing locations to meet local cash requirements. We cannot assure that we will continue to fund the manufacturing operations in any location, if such operations would require investment of additional cash from other jurisdictions.

Cash Flows

Cash Flow from Operating Activities ~~from Operations~~

Net cash used in operating activities ~~from operations~~ was $14.15 million for the ~~three~~ six months ended ~~March~~June 3130, 2019 compared to $02.41 million for the ~~three~~six months ended ~~March 31~~June 30, 2018. Net loss plus and minus non-cash adjustments (“cash loss”) declined by approximately $2.0 million for the ~~three~~six months ended ~~March 31~~June 30, 2019 compared to the same period in 2018. This decline was primarily driven by the receipt of the initial payment of $1.8 million under the ~~equipment~~Original Agreements ~~purchase agreement and the technology license agreement~~ during 2018.

Cash Flow from Investing Activities ~~from Operations~~

Net cash used in investing activities was $1.2 million and net cash provided by investing activities was $0.2 million for the ~~three~~six months ended ~~March~~June 3130, 2019 and 2018, respectively. We expect remaining 2019 consolidated capital expenditures to be approximately $2.4 million, of which $0.84 million is related to the high-end food packaging equipment as well as cost reduction products and $2.0 million is related to the New Agreements.

~~Cash Flow from Financing Activities from Operations~~24

~~Net~~Cash ~~cash~~Flow ~~provided~~from byFinancing ~~financing~~Activities activities was $2.1 million and net cash used in financing activities was $0.2 million for the three months ended March 31, 2019 and 2018, respectively, primarily due to funds received by our Spanish entity related to the STR Spain Loan.

Net cash provided by financing activities was $2.1 million and net cash used in financing activities was less than $0.1 million for the six months ended June 30, 2019 and 2018, respectively, primarily due to funds received by STR Spain related to the STR Spain loan in 2019.

Off-Balance Sheet Arrangements

We have no significant off–-balance sheet financing arrangements.

Effects of Inflation

Inflation generally affects us by increasing costs of raw materials, labor and equipment. During the first ~~three~~six months of 2019, we were not materially affected by inflation.

Recently Issued Accounting Standards

There are no new accounting pronouncements that we believe ~~will~~may have an impact on our consolidated financial statements.

24Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are not required to provide this Item 3. ~~Quantitative~~because ~~and~~we ~~Qualitative~~are ~~Disclosures~~a ~~about~~smaller reporting ~~Market Risk~~company.

~~We are not required to provide this~~ Item 34. ~~because~~Controls weand ~~are a smaller reporting company.~~Procedures

~~Item~~Disclosure 4. Controls and Procedures

~~Disclosure~~We ~~Controls~~maintain disclosure controls and ~~Procedures~~procedures that are designed to ensure that information required to be disclosed in our reports to the Securities Exchange Act of 1934, as amended (“Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms, and that such information is accumulated and communicated to our management, including our Chairman, President and Chief Executive Officer and our Vice President, Chief Financial Officer and Chief Accounting Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.

WeAs ~~maintain~~of ~~disclosure~~June 30, ~~controls~~2019, ~~and~~we ~~procedures~~carried ~~that~~out ~~are~~an ~~designed~~evaluation, under the tosupervision ~~ensure~~and ~~that~~with ~~information~~the ~~required~~participation toof beour ~~disclosed~~management, inincluding our ~~reports~~Chairman, toPresident ~~the~~and ~~Securities~~Chief ~~Exchange~~Executive ~~Act~~Officer ofand ~~1934~~our Vice President, asChief ~~amended~~Financial ~~(“Exchange Act”),~~Officer isand ~~recorded,~~Chief ~~processed~~Accounting Officer, ~~summarized~~of ~~and~~the ~~reported~~effectiveness ~~within~~of the ~~time~~design ~~periods~~and ~~specified~~operation inof ~~the~~our ~~SEC~~disclosure controls ~~rules~~ and ~~forms~~procedures, ~~and that~~as ~~such~~defined ~~information~~in isRules 13a-15(e) and ~~accumulated~~15d-15(e) under ~~and~~the ~~communicated~~Exchange toAct. ~~our~~Based ~~management,~~upon ~~including~~that evaluation, our Chairman, President and Chief Executive Officer and our Vice President, Chief Financial Officer and Chief Accounting Officer~~, as appropriate, to allow timely decisions~~ ~~regarding~~concluded ~~required~~that ~~disclosure.~~our ~~In designing and evaluating the~~ disclosure controls and procedures, ~~management~~are ~~recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives~~effective.

AsChanges of March 31, 2019, we carried out an evaluation, under the supervision and with the participation of our management, including our Chairman, President and Chief Executive Officer and our Vice President, Chief Financial Officer and Chief Accounting Officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in ~~Rules~~Internal ~~13a-15(e)~~Control ~~and~~Over ~~15d-15(e) under the Exchange Act. Based upon that evaluation, our Chairman, President and Chief Executive Officer and our Vice President, Chief~~ Financial ~~Officer and Chief Accounting Officer concluded that our disclosure controls and procedures are effective.~~Reporting

~~Changes~~There have not been any changes in ~~Internal~~our ~~Control~~internal control over ~~Financial~~financial reporting ~~Reporting~~(as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the second fiscal quarter of our fiscal year ended December 31, 2019 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

~~There~~PART II. ~~have~~OTHER not been any changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the first fiscal quarter of our fiscal year ended December 31, 2019 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.INFORMATION

~~PART~~Item II1. ~~OTHER~~Legal ~~INFORMATION~~Proceedings

~~Item~~From 1.time ~~Legal~~to ~~Proceedings~~time, we are and have been a party to litigation that arises in the ordinary course of our business.

~~From time to time, we are and have been a party to litigation that arises in the ordinary course of our business.~~25

In ~~October~~ 2016, athe ~~complaint~~Company ~~was~~ filed bysuit ~~Solaria~~against ~~Energia~~CEEG y(Nanjing) ~~Medio~~Renewable ~~Ambiente~~Energy SCo.A, Ltd. (“~~Solaria~~NRE”), ~~against~~ the ~~Company~~parent ~~and~~company ~~its~~of ~~Spanish~~our ~~subsidiary,~~former ~~STR~~customer ~~Spain,~~CSUN in ~~the~~Nanjing Jiangning District People’s Court, ofChina (the ~~First~~“Nanjing ~~Instance No~~Court”). 8In ina ~~Oviedo~~hearing held on August 10, ~~Spain~~2016, ~~relating~~the toNanjing aCourt ~~product~~found ~~quality~~NRE ~~claim~~delinquent in making ~~connection~~payment ~~with~~against abona ~~non-encapsulant~~fide ~~product~~invoices ~~that~~dating ~~STR~~back ~~Spain~~to ~~purchased from~~April a2015 ~~vendor~~and inordered ~~2005~~NRE ~~and~~to ~~2006~~pay ~~and~~the ~~resold~~Company tothe ~~Solaria~~amount of RMB8.8 ~~The~~million for ~~Company~~encapsulant ~~stopped~~sold ~~selling~~to ~~this~~CSUN, ~~product~~court infees, ~~2006~~interest and attorney fees. ~~Solaria~~Following ~~was~~the ~~seeking~~subsequent ~~approximately €3.3~~failure ~~million~~of ~~(approximately~~NRE ~~$3.7~~to ~~million~~pay asaccording to the order of ~~March~~the ~~31,~~Nanjing ~~2019)~~Court, ~~plus~~the ~~interest,~~Company ininitiated ~~damages.~~enforcement Aproceedings ~~trial~~in ~~was~~the ~~held~~enforcement ondepartment ~~April~~of 6,Nanjing ~~2017,~~Court inand ~~Oviedo~~ultimately agreed to accept installment payments managed through the Nanjing Court, ~~Asturias~~the first of which came due on February 28, ~~Spain~~2018 and remains unpaid. OnThe ~~January~~Company 9,has ~~2019~~since filed an application for the resumption of enforcement, for which the ~~judge~~Nanjing Court ~~issued~~has aacknowledged ~~ruling~~receipt. ~~dismissing~~The ~~Solaria’s~~Nanjing ~~case,~~Court ~~and~~has informed the ~~appeal~~Company ~~period~~that it will schedule another hearing to take further ~~ended~~actions onagainst ~~February~~NRE 8and its Chairman, ~~2019~~Mr. ~~with~~Lu noTingxiu, ~~appeal~~to ~~filed~~compel NRE to pay the Company according to the court order currently in force. The Company ~~now~~has ~~considers~~been advised that it is highly unlikely that the ~~matter~~Company ~~closed~~will recover any of the funds due.

In 2016, the Company filed suit against CEEG (Nanjing) Renewable Energy Co., Ltd. (“NRE”), the parent company of our former customer CSUN in Nanjing Jiangning District People’s Court, China (the “Nanjing Court”). In a hearing held on August 10, 2016, the Nanjing Court found NRE delinquent in making payment against bona fide invoices dating back to April 2015 and ordered NRE to pay the Company the amount of RMB8.8 million for encapsulant sold to CSUN, court fees, interest and attorney fees. Following the subsequent failure of NRE to pay according to the order of the Nanjing Court, the Company initiated enforcement proceedings in the enforcement department of Nanjing Court and ultimately agreed to accept installment payments managed through the Nanjing Court, the first of which came due on February 28, 2018 and remains unpaid. The Company has since filed an application for the resumption of enforcement, for which the Nanjing Court has acknowledged receipt. The Nanjing Court has informed the Company that it will schedule another hearing to take further actions against NRE and its Chairman, Mr. Lu Tingxiu, to compel NRE to pay the Company according to the court order currently in force.

Item 1A. Risk Factors

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2018, as amended, which could materially affect our business, financial position and results of operations. There have been no material changes to the risk factors as disclosed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2018, as amended.

Item 5.

Other Information

None.

Item 6.

Exhibits

*10.1		English translation of Mortgage Loan, dated as of March 20, 2019, by and between Specialized Technology Resources España, S.A. and Sociedad Regional de Promoción del Principado de Asturias, S.A. (filed as Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q filed on May 14, 2019 and incorporated herein by reference).
*10.2		English translation of Comfort Letter, dated as of January 8, 2019, by and between Specialized Technology Resources, S.A.U. and Sociedad Regional de Promoción del Principado de Asturias, S.A. (filed as Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q filed on May 14, 2019 and incorporated herein by reference).
*23.1		Consent of UHY LLP, Independent Registered Public Accounting Firm.
31.1		Certification of Chief Executive Officer pursuant to Rule 13a-14 Securities Exchange Act Rules 13a-14(a) and 15d-14(a), pursuant to section 302 of the Sarbanes-Oxley Act of 2002.
31.2		Certification of Chief Financial Officer pursuant to Rule 13a-14 Securities Exchange Act Rules 13a-14(a) and 15d-14(a), pursuant to section 302 of the Sarbanes-Oxley Act of 2002.
32.1		Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted by Section 906 of the Sarbanes-Oxley Act of 2002.
32.2		Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted by Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS		XBRL Instance Document
101.SCH*		XBRL Taxonomy Extension Schema Document
101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF		XBRL Definition Linkbase Document
101.LAB		XBRL Taxonomy Extension Label Linkbase Document
101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document

~~_________________~~* Filed herewith.

* Filed herewith.27

27SIGNATURE

~~SIGNATURE~~Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	STR HOLDINGS, INC.
	(Registrant)

Date: August 14, 2019	/s/ thomas d. vitro
	Name:	Thomas D. Vitro
	Title:	Vice President, Chief Financial Officer and Chief Accounting Officer
		(Duly Authorized Officer and Principal Financial Officer)

	STR HOLDINGS, INC.
	(Registrant)
Date: May 14, 2019	/s/ Thomas D. Vitro
	Name:	Thomas D. Vitro
	Title:	Vice President & Chief Financial Officer
		(Duly Authorized Officer and Principal Financial Officer)

Filing Compare · STR HOLDINGS, INC.